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ABSTRACT
THE MECHANISM OF CASPASE-8-MEDIATED GENE EXPRESSION AND ITS
INTEGRAL ROLE IN HOST DEFENSE
Alexandra Anne DeLaney
Igor E. Brodsky, Ph.D.
Caspase-8 is a key integrator of cell survival and cell death decisions during
infection and inflammation. Additionally, caspase-8 has an important, but less understood,
role in cell-intrinsic inflammatory gene expression. Macrophages lacking caspase-8 have
defective inflammatory cytokine expression in response to bacterial infection or TLR
stimulation. How caspase-8 regulates cytokine gene expression, and whether caspase-8mediated gene regulation has a physiological role during infection remains poorly defined.
In this thesis we demonstrate that both caspase-8 enzymatic activity and scaffolding
functions play a role in control of inflammatory cytokine gene expression. Caspase-8
enzymatic activity mediates IKK phosphorylation and nuclear translocation of the NF-κB
family member c-Rel to promote maximal expression of Il1b and Il12b. Overexpression of
c-Rel was sufficient to restore expression of IL-12 and IL-1β in caspase-8-deficient cells.
Moreover, the cytokine regulatory function of caspase-8 promoted host survival during
infection by the intracellular parasite Toxoplasma gondii. Caspase-8-deficient mice
displayed acute mortality during T. gondii infection and a defect in intracellular IL-12
production by DCs. Exogenous IL-12 promoted complete survival of caspase-8-deficient
mice during acute toxoplasmosis. Our findings provide new insight into how caspase-8
controls inflammatory gene expression and, for the first time, identify a critical role for
caspase-8 in host defense against a eukaryotic pathogen.
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CHAPTER 1: Introduction
1.1 Innate immune sensing
The innate immune system is the first line of defense in the host response to insult
or injury from the environment. Often this injury is triggered by attack from microbes such
as bacteria, viruses, protozoan parasites, or prions. After a breach of physical barrier sites
such as the skin, the innate immune system must (1) recognize this diverse group of
microbes as a threat to the host, (2) activate inflammatory mediators to promote microbe
clearance and host survival, and ultimately (3) trigger the adaptive immune response to
promote long-term protection.
For many years, addressing the way innate immune cells recognized such a diverse
group of organisms in the absence of antigen specificity was an open question in the field
of immunology. It was not until Dr. Charles Janeway proposed the Pattern Recognition
framework—in which he hypothesized that innate immune cells recognize conserved
microbial products known as Pathogen-Associated Molecular Patterns (PAMPs) through
Pattern Recognition Receptors (PRRs) expressed on their surface—that immunologists had
a comprehensive framework explaining how this process might occur in the host [1]. While
Dr. Janeway’s prediction was not demonstrated experimentally until the mid 1990s [2-4],
it has become a foundational pillar for our understanding of the ways in which host innate
immune cells distinguish self from non-self. Subsequent groups have gone on to
characterize a wide variety of PRRs that are expressed on the cell surface, intracellular
membranes, and the cytoplasm [5, 6, 7, 8]. Moreover, we now know that PRRs are not
restricted to innate immune cells, such as macrophages or dendritic cells, but are expressed
on a variety of other immune cell types [9] as well as non-immune cells such as fibroblasts
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[10] and epithelial cells [11-13]. PRR stimulation promotes functional alterations in these
cell types that are critical for both immune activation and host homeostasis [14-16].
Recently our appreciation for the robust colonization of mammalian hosts by nonself-microbes, such as the billions of bacteria and viruses in our intestinal tract [17], has
raised a conceptual problem for the understanding of how PRR activation and
inflammation target pathogenic microbes specifically. Under homeostatic conditions the
host gut is not constitutively inflamed [18]. In fact it is hypothesized that commensal
microbes conferred an evolutionary fitness advantage for our ancestors, allowing them to
efficiently acquire nutrients and prevent colonization by pathobionts [19-21]. In exchange
our guts provide a replicative niche for these commensals. How can we reconcile this with
the knowledge that the PAMPs expressed by these commensal microbes are
indistinguishable from pathogens? How does the host specifically promote clearance of
pathogens while preserving beneficial microbes? One solution lies in the properties of the
inflammatory networks activated in response to PRR stimulation. These networks are not
on/off switches, rather they are regulated by a variety of intracellular factors that can
dampen [22, 23] or heighten [24] the inflammatory signal. We are continually expanding
the list of host factors that allow cells to fine-tune the inflammatory response. The aim of
this thesis is to address the contribution of the cysteine protease caspase-8 to the regulation
of inflammation in response to PRR activation, and to build upon our current understanding
of the intracellular mechanisms that regulate activation in response to microbial products
originating from both commensal and pathogenic organisms.
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1.1.1 Overview of Toll-like-receptor activation and gene transcription.
Toll-like receptors (TLRs) are a subset of PRRs that act as sensors for microbial
products [2, 3, 25, 26]. TLRs can be expressed on the cell surface (TLR1, TLR2, TLR4,
TLR5 [27], TLR6, and TLR10) or on endosomal membranes (TLR3 [28], TLR7 [29],
TLR8, TLR9 [30], TLR11 [31], TLR12, and TLR13) [32]. Broadly, cell surface TLRs
recognize microbial membrane components [33], and endosomal TLRs recognize
microbial nucleic acids [34]. Activation of TLRs via the detection of PAMPs leads to the
recruitment of the adapter proteins MyD88 (Myeloid differentiation primary response 88)
and TRIF (TIR-domain-containing adapter-inducing interferon-β) [35-37].These adapter
proteins mediate the induction of intracellular signaling cascades that ultimately activate
the transcription factors NF-κB (nuclear factor kappa-light-chain-enhancer of activated B
cells), AP-1(Activator protein 1) and IRF3 (Interferon regulatory factor 3) [38, 39, 40].
These transcription factors in turn promote upregulation of inflammatory molecules that
directly or indirectly promote killing of microbes [41-44](Figure 1.1). The roles of MyD88
and TRIF are non-redundant as Myd88-/- and Trif-/- mice are differentially susceptible to
infection with bacteria [45, 46] and viruses [35], respectively. TLR4, which recognizes a
component of the cell wall of gram-negative bacteria known as lipopolysaccharide (LPS),
is unique in that it is the only TLR that signals through both MyD88 and TRIF—MyD88
when TLR4 is expressed at the plasma membrane and TRIF after TLR4 endocytosis [47,
48]. Although TLRs signal through a common set of adaptor proteins (TLR4 and TLR3
through TRIF and TLR4 along with all other TLRs through MyD88), it has been recently
appreciated that the magnitude and breadth of this response is not uniform across all TLRstimuli [49]. This appreciation for the divergent activation of transcriptional responses
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downstream of TLR stimulation has led to a body of work aimed at determining how
signals from these common adaptors and transcription factors lead to unique gene
expression patterns [50-52]. While significant progress has been made in defining the
regulatory mechanisms by which common TLR-inputs are integrated into divergent gene
expression outputs, these studies are by no means exhaustive, creating a gap in our
knowledge surrounding one of the most fundamental aspects of the innate immune system.

1.1.2 Overview of NF-κB-dependent gene regulation in macrophages.
TLR-mediated activation of NF-κB induces the upregulation of pro-inflammatory
mediators and antimicrobial peptides to promote killing of microbes [53-55]. NF-κB
transcription factors are a family of five proteins that form active homo- and heterodimers
to mediate gene expression [56](Figure 1.2). They are constitutively expressed in
macrophages, and held in the cytoplasm by negative regulators from the IκB family; these
negative regulators are degraded in response to TLR activation via the 26S proteasome [57,
58](Figure 1.2). Degradation of IκB proteins allows NF-κB dimers to translocate to the
nucleus and induce the expression of their target genes. NF-κB signaling is often used as a
classic example of a negative feedback loop in biology, as the genes encoding inhibitory
IκB proteins are among the many transcriptional targets for NF-κB dimers [59]. This
provides an elegant mechanism to prevent chronic induction of inflammatory mediators
triggered by TLR activation.
In macrophages NF-κB gene targets can be categorized into primary and secondary
response genes [60] that are thought to be organized by lineage determining factors
expressed during macrophage development [61, 62]. As the name implies, primary
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response genes are poised for rapid transcription due to their (1) open chromatin state, (2)
limited occupation by nucleosomes, (3) independence from SWI/SNF-mediated chromatin
modification, and (4) poised RNA polymerase II at their promoters [63-65]. However,
secondary response genes require chromatin remodeling [66, 67] and RNA polymerase II
recruitment to initiate transcription. Macrophage chromatin organization creates a temporal
hierarchy for inflammatory gene expression through the division of gene accessibility to
transcription factors such as NF-κB proteins [68, 69]. In macrophages the TLR4 agonist,
LPS, is one of the most potent activators of NF-κB-dependent gene transcription, which is
thought to be primarily dependent on the activity of p65 [70]. However, seminal work has
shown that a less well-characterized NF-κB protein, c-Rel, is specifically required for the
transcription of the secondary response gene Il12b [71], which encodes the IL-12p40
subunit of IL-12p70 and IL-23, two cytokines essential for host defense against a variety
of pathogens [72-74]. Data from our lab as well as others has shown a requirement for the
cysteine protease caspase-8 in cytokine production in response to LPS and other TLR
ligands such as Poly I:C (TLR3) and CpG (TLR9) [75-78]. Uniformly the gene we found
to be most differentially affected by the absence of caspase-8 was Il12b [75]. Caspase-8
affects Il12b transcription downstream of both TLR3, which is TRIF-dependent, and
TLR9, which is MyD88-dependent. This suggests that in macrophages caspase-8 may
serve as signaling node that enhances the magnitude of inflammatory cytokine expression
in response to all TLRs regardless of their respective adaptor proteins. In Chapter 2 we
identify the diversity of caspase-8-dependent genes induced in response to TLR4 and TLR9
activation.
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1.1.3 Overview of caspase-8 biology.
Caspase-8 belongs to a family of pro-enzymes, termed caspases, which are
activated by homodimerization and auto-processing [79-81]. Caspase-8 consists of tandem
N-terminus death effector domains (DED) [82] that promote homotypic interactions
between other DED-containing proteins, and a C-terminus catalytic domain that is autoprocessed during homodimerization to form the p20 and p10 subunits of the apoptotic
formation of caspase-8 (Figure 1.3A). Upon activation of death receptors, such as TNFR
(Tumor necrosis factor receptor) or Fas/CD95, the adaptor protein TRADD (Tumor
necrosis factor receptor type 1-associated death domain protein) is recruited via homotypic
interaction between its death domain and that of the death receptor [83, 84] (Figures 1.3B
and 1.3C). TRADD then recruits FADD (FAS associated death domain), which contains
both a death domain and death effector domain, thereby allowing for the recruitment of
RIPK1

(Receptor-interacting

serine/threonine-protein

kinase

1)

and

caspase-8,

respectively [85]. These proteins assemble to form the death inducing signaling complex
(DISC) [86] then are rapidly endocytosed to form a cytoplasmic supramolecular complex
known as Complex II [87]. Complex II serves as a platform for apoptotic signaling [87,
88] (Figure 1.3C). Under pro-survival conditions, such as TNF stimulation, some deathinducing proteins remain at the plasma membrane and promote activation of NF-κB and
MAPK through TRADD-mediated recruitment of TRAF2 (TNFR associated factor 2)
(Figures 1.1 and 1.3C) [89-94]. Under these pro-survival conditions, the expression of a
catalytically inactive homolog of caspase-8, cFLIP (cellular FLICE like inhibitory protein),
prevents caspase-8 auto-processing, thereby inhibiting caspase-8 apoptotic activity [91, 95,
96]. TLR or TNFR stimulation coupled to chemical- or pathogen-mediated blockade of
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gene transcription results in activation of Complex II, and a decrease in cFLIP expression
[97-101]. These two signals promote the auto-processing of caspase-8 monomers and
cleavage of downstream substrates to induce cell-extrinsic apoptosis (Figure 1.3C) [102,
103].
Recently, it has also been appreciated that caspase-8 constitutively represses
another form of cell death known as programmed necrosis [104, 105]. Both the nonapoptotic and apoptotic conformations of caspase-8 represses RIPK3- (Receptorinteracting serine/threonine protein-kinase 3) mediated programmed necrosis through the
constitutive cleavage of the lysine 63 deubiquitinase CYLD [106, 107]. CYLD cleaves
K63 ubiquitin on RIPK1 promoting its dissociation from Complex II and promoting
association with RIPK3 via homotypic interactions in their RHIM (RIP homotypic
interaction motif) domains [108]. This interaction in turn leads to the phosphorylation of
MLKL (Mixed lineage kinase domain like pseudokinase), oligomerization and plasma
membrane disruption (Figure 1.3C) [109]. Previously, caspase-8-deficient animals were
not viable because of the requirement for caspase-8-mediated repression of necrosis during
embryonic development. The generation of Ripk3-/-Casp8-/- mice [104, 105] has provided
a genetic tool to investigate the role of caspase-8 in inflammatory gene regulation without
the confounding role of programmed necrosis. Using Ripk3-/-Casp8-/- mice as a tool, our
lab, as well as other labs, have shown a role for caspase-8 in inflammatory cytokine
production apart from its role in apoptosis and programmed necrosis [75-78, 110, 111].
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1.1.4 Caspase-8 mediates cytokine secretion.
The enzymatic properties of caspase-8 that mediate cytokine secretion have yet to
be elucidated. Caspase-8 likely has both scaffolding and enzymatic functions within the
cell, but the relative contributions of scaffolding and enzymatic activity to gene expression
has not been directly tested in response to TLR stimulation. Early it was reported that the
pro-domains of caspase-8 were sufficient to mediate NF-κB signaling [78]. Recently,
caspase-8 scaffolding has been implicated in TRAIL (TNF related apoptosis inducing
ligand)-induced inflammatory gene expression in HeLa cells [112]. However, we
previously observed that treatment of RIPK3-deficient macrophages with a caspase-8specific inhibitor reduced inflammatory cytokine production during TLR stimulation [75].
To address this potential discrepancy, and to mechanistically dissect the contribution of
caspase-8 to macrophage inflammatory gene expression, we examined the roles of both
caspase-8 scaffolding and enzymatic activities in regulation of NF-κB signaling. One
approach we took to address this question was to generate a mouse expressing a
catalytically active, non-cleavable form of caspase-8 in which the linker region between
the p20 and p10 subunits is mutated from an aspartic acid to an alanine, inhibiting autoprocessing and stabilization of the apoptotic conformation of caspase-8 while preserving
protein expression and its cytokine regulatory function (Figure 1.3A) [80, 113]. These
mice will be referred to as Casp8DA/DA. We have previously shown that bone marrow
derived macrophages (BMDMs) from these mice are resistant to apoptosis induced via
infection with the gram-negative bacterial pathogen Yersinia pseudotuberculosis (Yp) [75].
Yp is a potent activator of caspase-8-dependent apoptosis in macrophages [97, 100, 114],
but Casp8DA/DA BMDMs do not undergo apoptosis, and maintain their ability to secrete
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inflammatory cytokines when stimulated with TLR ligands [75]. A combination of
chemical inhibition of caspase-8 activity, genetic ablation of caspase-8, and specific
mutation of caspase-8 apoptotic activity have allowed us to investigate both the mechanism
by which caspase-8 regulates inflammatory gene expression (Chapter 2) in response to
TLR stimulation, and the enzymatic requirements of caspase-8 in this context (Chapter
3).

9

1.2 Role of apoptosis and cytokine secretion in host defense
The hallmarks of inflammation—redness, swelling with heat, and pain—were first
described by the Roman physician Cornelius Celsus in the first century A.D. [115].
Subsequent discoveries identified the soluble factors, which we now refer to as cytokines,
that mediated some of the observed characteristics of inflammation, resulting in the
identification of TNF in 1975 and IFN in 1978 [116-118]. Cytokines are defined as “soluble
factor[s] produced by one cell and acting on another cell, in order to bring about a change
in the function of the target cell” [119]. This broad definition encompasses an array of
functions within the host of which signaling during inflammation is but one. The protective
effect of cytokines has been appreciated since the observation that endotoxin-induced TNF
was cytotoxic to tumor cells [116]. Moreover, in the early 80s Cantell and others began
purifying bulk IFN preps from human donor cells stimulated with Sendai Virus for human
clinical trials [120]. However, prolonged secretion of cytokines can also have detrimental
effects, and chronic inflammation mediated by cytokines has been implicated in diseases
such as diabetes, rheumatoid arthritis, Crohn’s disease, and plaque psoriasis [121-124]. As
such there is considerable interest in identifying the mechanisms by which the host immune
system secretes inflammatory mediators to promote acute clearance of pathogens, but
controls long-term release to prevent tissue damage and host mortality.
A second line of defense in control of microbial infection is programmed cell death,
which allows the host to destroy the infected cell, control pathogen spread, and promote
the release of danger-associated molecular patterns (DAMPs) that signal to bystander cells.
Both caspase-8 enzymatic activity and scaffolding are implicated in many of these
programmed cell death pathways. Caspase-8 plays a role in host defense during pyroptosis
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[77, 125, 126], programmed necrosis [127], and apoptosis [128] during both viral and
bacterial infection. Apoptosis is unique in that under developmental and homeostatic
conditions it is largely thought to be immunologically silent [129]. However, there are
contexts in which apoptosis can be inflammatory [130, 131], particularly when it is coupled
to infection [98, 132]. In investigating the role of apoptosis in host defense we discovered
that the caspase-8 serves as a bridge between the regulation of cell death and cytokine
production in response to PAMP stimulation [75]. Given the role of both cell death and
cytokine production in host defense during infection we sought to determine the relative
contributions of both caspase-8-mediated cytokine secretion and caspase-8-mediated cell
death in this context.

1.2.1. Caspase-8 deficiency leads to embryonic lethality.
Caspase-8 negatively regulates programmed necrosis through the constitutive
cleavage of the lysine 63 deubiquitinase CYLD [133]. For this reason, the single ablation
of caspase-8 results in lethality ten days into embryonic development. Dual ablation of
caspase-8 and RIPK3, a mediator of programmed necrosis, yield viable mice with normal
development [104, 105]. However, beginning at 6 weeks Ripk3-/-Casp8-/- mice display
lymphadenopathy and splenomegaly that is attributed to the accumulation of lymphocytes,
specifically a CD4-CD8-CD3+B220+ adaptive population of T cells [105]. Conditional
deletion of caspase-8 using the Cre/LoxP system in specific cell lineages leads to activation
of programed necrosis upon cell stimulation [107, 134]. Therefore, Ripk3-/-Casp8-/- mice
are currently the best tool to study caspase-8-mediated apoptosis and cytokine secretion
during host defense in vivo. Recently, we have also generated a mouse, Casp8DA/DA,
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sufficient for the cytokine regulatory function of caspase-8, but not its apoptotic activity
(Section 1.1.4) [75]. These mice were also bred to Ripk3-/- mice to create Ripk3-/Casp8DA/DA mice. Ripk3-/-Casp8DA/DA mice should not be able to undergo apoptosis or
programmed necrosis, but should be able to produce caspase-8-dependent inflammatory
cytokines. We have performed preliminary characterizations of the developmental
phenotype of these mice that will be described in Chapter 4 as well as infections with
Toxoplasma gondii and Yersinia pseudotuberculosis that are discussed in Chapters 5 and
6, respectively.

1.2.2 Role of caspase-8 in host survival during acute Toxoplasma gondii infection.
The protozoan parasite T. gondii infects warm-blooded animals via ingestion of
oocysts shed in the feces of the parasites’ obligate hosts: members of Felidae family
(domestic cats) [135]. The CDC estimates that 40 million adults, adolescents, and children
are infected at any given time in the U.S., and that Toxoplasma spp. are the leading cause
of foodborne-related deaths [136]. Early work investigating the mechanisms of immune
protection against T. gondii-infection identified the cytokine IL-12p70 as a key mediator
of host defense [137]. C57BL/6 mice clear infection with the attenuated Prugniaud (Pru)
strain of T. gondii within 30 days, and this clearance is dependent on the early production
of IL-12p70 [138]. IL-12p70 secreted by conventional dendritic cells (cDCs) promotes
early release of NK cell IFNγ as well as a CD4 and CD8 T cell recruitment [139]. These
events lead to myeloid- and T-mediated killing of infected cells [140-143].
Interestingly, the cytokine that is most affected by the loss of caspase-8 is IL-12p40
[75], but to our knowledge no one had identified a role for caspase-8 in protection against

12

T. gondii. Caspase-8-mediated apoptosis is not thought to play a role in host defense during
T. gondii infection as the parasite actively suppresses apoptotic signaling [144, 145]. For
these two reasons we hypothesized that caspase-8-mediated cytokine production—not cell
death—is required for survival during acute T. gondii infection. The results from these
studies are described in Chapter 5.

1.2.3 Caspase-8 mediates host survival in response to Yersinia pseudotuberculosis.
Previous work from our lab as well as others has shown that caspase-8 plays a cellintrinsic role in cytokine production in response to gram-negative bacterial infections [7577, 100, 110, 146] and fungal infections [147]. These data suggest that caspase-8dependent cytokine production may promote antimicrobial host defense independently of
its apoptotic activity. One potent activator of caspase-8-dependent apoptosis and cytokine
production is Yersinia pseudotuberculosis, a gram-negative bacterial pathogen that causes
self-limiting gastroenteritis in humans [148, 149], but in mice mimics infection with the
related species Yersinia pestis, the causative agent of plague [150-152]. Yersinia pestis is
still endemic in the United States, with a mortality rate between 30-90% when left untreated
[153], making it not only a model to dissect the dual functions of caspase-8 in host defense,
but also a pathogen of broad public health relevance. Yersinia pseudotuberculosis
expresses seven effector proteins known as Yersinia outer proteins (Yops) that are injected
into target cells through a needle like structure known as the Type III secretion system
[154, 155]. One of these effectors, YopJ, blocks MAPK and NF-κB signaling, leading to
the activation of caspase-8-mediated apoptosis (Figure 1.5) [154]. Injection of YopJ occurs
within the first hour of infection and results in irreversible cell death within 4 hours in vitro
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[132, 156]. We have previously shown that sublethally irradiated C57BL/6 mice
reconstituted with Ripk3-/-Casp8-/- bone marrow infected orally with Yersinia
pseudotuberculosis have a cell-intrinsic defect in cytokine secretion, and an acute survival
defect [114]. However, these data do not address whether caspase-8-mediated apoptosis or
caspase-8-mediated cytokine production promote host survival in this context. Therefore,
we sought to determine the relative contributions of both caspase-8-mediated cell death
and inflammatory cytokine production to host survival during infection with Yersinia
pseudotuberculosis (Chapter 6).

1.2.4 Caspase-8 deficiency in humans leads to acute susceptibility to microbial infection.
A majority of the mechanistic research interrogating the apoptotic- and immune
signaling-functions of caspase-8 have been performed using mice and mouse cells.
However, there are humans with a caspase-8 deficiency. These patients were identified in
2001 as a brother and sister whose asymptomatic parents possessed a heterozygous
mutation that rendered caspase-8 catalytically inactive and the protein unstable [157]. The
clinical history of these patients revealed ongoing, acute susceptibility to microbial
infections, suggesting that caspase-8-induced control of cell death contributes to
antimicrobial defense [157]. However, B, NK, and T cells from these patients had defects
in activation, which was attributed to impaired NF-κB signaling mediated through caspase8 [78, 157-159]. These data raised the possibility that these patients’ susceptibility to
microbial infection may involve caspase-8-mediated control of immune cell activation in
lieu of caspase-8-mediated cell death.
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Subsequent studies investigating the role of caspase-8 in T cell activation in mice
using the dual ablation of caspase-8 and RIPK3 showed no defects in T cell activation or
defects in T cell expansion after infection with LCMV Armstrong (Lymphocytic
Choriomeningitis virus) or MHV (Mouse Herpes virus) [134, 160]. One explanation of this
discrepancy is that there are human- and mouse-specific signaling mechanisms that dictate
the differential impact of caspase-8 on immune cell activation. It also possible that this
difference can be attributed to the expression of the caspase-8 homolog caspase-10 in
humans and not rodents [161]. In fact, redundancy between caspase-8 and caspase-10 in
humans was offered as an explanation for the ability of humans to survive embryonic
development without functional caspase-8 [157]. However, we are optimistic that our
investigations of caspase-8 in inflammatory gene expression and host defense will provide
some basis for further investigations into caspase-8-specific functions in human immune
cells.
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1.3 Summary
Caspase-8 is uniquely poised at the interface of cell death and cytokine
production—two essential biological processes that mediate host defense. Understanding
both (1) the mechanism of caspase-8 dependent cytokine production and (2) the relative
contributions of caspase-8-mediated cell death and cytokine secretion to host survival will
allow us to elucidate how host immune cells are able to switch between expression of proinflammatory mediators and cell death during infection. The aim of this project was to
begin to resolve two conceptual and scientific gaps in the field of caspase-8 biology,
thereby expanding our understanding of the intimate integration of inflammation and cell
death.
One gap in knowledge was the structural requirements of caspase-8 that mediate its
immune regulatory function. Some hypothesize that caspase-8 serves as a scaffolding
platform for signal transduction that leads to gene expression [111, 112]. However, data
from our lab suggest that caspase-8 enzymatic activity is required for maximal cytokine
expression [75]. Chapters 2 and 3 seek to address this question in the context of
macrophage gene expression.
The second gap is the broader question of the mechanism by which caspase-8
promotes host defense. Given the observation that humans with caspase-8 deficiencies
experience chronic infection with a variety of pathogens, and the requirement for caspase8 in mouse survival during infection with Yersinia pseudotuberculosis, we sought to
address the question of what biological property or properties of caspase-8 contribute to
host protection. Previous work from our lab as well as others has demonstrated a broad
cell-intrinsic role for caspase-8 in the regulation of immune cell homeostasis, inflammatory
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cell death, and inflammatory gene expression. The spectrum of caspase-8 cellular functions
provide several potential mechanisms by which caspase-8 promotes host survival during
microbial infection. Data from Chapters 5 and 6 seek to address this question during acute
infection with Toxoplasma gondii and Yersinia pseudotuberculosis, respectively.
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1.4 Figures

Fig 1.1 Schematic of signal transduction induced in response to TLR stimulation[162, 163].
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Fig 1.2 Schematic of NF-κB and IκB protein structure [56].
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Fig 1.3 Schematic of proteins involved in death receptor signaling and the signal
transduction cascade that mediates apoptosis and programmed necrosis [83, 87, 96].
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Fig 1.4. Model of IL-12-mediated clearance of Toxoplasma gondii infection.
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Fig 1.5 Schematic of Yersinia pseudotuberculosis-induced apoptosis in macrophages.
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CHAPTER 2: Caspase-8 regulates TLR-induced macrophage gene
expression through the NF-κB family member c-Rel.
2.1 Abstract
Our group as well as others have shown that caspase-8 has an important role in cellintrinsic inflammatory gene expression. Macrophages lacking caspase-8 or the adaptor
protein FADD have defective inflammatory cytokine expression, and inflammasome
priming in response to bacterial infection and TLR stimulation. Macrophage cytokine
secretion is a key regulator of host innate immunity. Therefore, defining the regulatory
mechanisms that promote macrophage-mediated cytokine expression are essential to the
development of clinical therapies that target these signaling pathways. We sought to
specifically define the mechanism of caspase-8-dependent gene regulation in the context
of TLR stimulation. Here we demonstrate that caspase-8 regulates a broad repertoire of
inflammatory genes in response to multiple TLRs, and that caspase-8 exerts this function
in part through regulation of IKK phosphorylation. This differential IKK phosphorylation
affects translocation of the NF-κB family member c-Rel, but not p65, and overexpression
of c-Rel was sufficient to restore expression of IL-12 and IL-1β in caspase-8-deficient cells.
IKK phosphorylation in response to TLR4 and TLR9 is dependent on the presence of the
adaptor protein FADD suggesting a mechanism by which both TLR activation and death
receptor activation are coupled to caspase-8 signaling in macrophages. These findings
provide new insight into a novel regulatory mechanism for the transcription factor c-Rel
via caspase-8-mediated activation of IKK phosphorylation.
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2.2 Introduction
Caspase-8-mediated apoptosis plays a critical role in immune homeostasis through
the clearance of autoreactive cells [164-166], and tumor suppression [167]. Therefore,
there has been considerable effort in elucidating the regulatory mechanisms governing this
form of cell death. These studies have helped identify the critical adaptor molecules FADD
[168, 169] and TRADD [170] that mediate caspase-8-recruitment to the death receptors
Fas and TNFR1/2 respectively as well as the signals that govern the switch from prosurvival signaling at the plasma membrane to apoptotic signaling via Complex II in the
cytoplasm [92, 93]. However, there is evidence that caspase-8 plays a role in host survival
beyond its role in cell-extrinsic apoptosis.
Original reports of caspase-8 mutations in humans identified defects in T, B and
NK cell activation [157], and subsequent work demonstrated that caspase-8 regulates
NF-κB activation through interactions with NIK (NF-κB-inducing kinase) and RIKP1 [78].
These data led to the hypothesis that caspase-8 regulates lymphocyte activation through
NF-κB signaling. This mechanism that was seemingly confirmed by subsequent studies in
mice showing a role for caspase-8 in B cell survival in response to TLR stimulation, and
decreased NF-κB signaling in the absence of caspase-8 in other cell types [158, 159].
However, two seminal studies published simultaneously in 2011 demonstrated a role for
caspase-8 in the repression of another cell death pathway: programmed necrosis [104, 105].
In the absence of caspase-8 there is a de-repression of RIPK1/RIPK3-dependent
programmed necrosis during embryonic development [92, 104, 105]. Dual ablation of
caspase-8 and RIPK3 led to viable progeny, and abrogated the constitutive activation of
programmed necrosis in response to death-inducing stimuli [105]. It was also shown that
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caspase-8 negatively regulates programmed necrosis through the constitutive cleavage of
the deubiquitinase CYLD [133]. CYLD cleaves K63 ubiquitin on RIPK1 which leads to
its interaction with RIPK3 and subsequent activation of programmed necrosis [106].
These new data raised the possibility that previous studies demonstrating a role for
caspase-8 in NF-κB signaling downstream of lymphocyte activation were confounded by
the role of caspase-8 in the regulation of programmed necrosis. It was possible that the
observed phenotype in lymphocytes was due to a defect in survival and not activation. In
fact studies testing the impact of dual ablation of caspase-8-dependent apoptosis and
RIPK3-mediated programmed necrosis in T cells showed no defect in proliferation—these
mice also display normal T cell activation after infection with MHV [160]. These data
conflict with earlier reports that caspase-8 was required for T cell activation in humans:
T cells isolated from caspase-8-deficient patients had a decrease in IL-2 release after TCR
stimulation [157]. However, these earlier studies did not test if these cells were dying in
response to TCR activation which is a possible experimental outcome given our current
understanding of caspase-8-dependent regulation of programmed necrosis. Another
potential explanation for this discrepancy is that there are mouse- and human-specific
differences in T cell activation after TCR stimulation, but these investigators did not
directly test cell death in these cultures so this conflict remains unresolved.
Our initial interest in caspase-8 biology arose from its role in cell death in response
to microbial infection. It has long been appreciated that apoptosis promotes clearance of
virally infected cells, illustrated by the evolution of viral antagonism of caspase-8-mediated
apoptosis [171, 172]. However, the role of caspase-8 in response to bacterial infection has
yet to be completely defined. The gram-negative bacterial pathogen Yersinia
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pseudotuberculosis (Yp), causes self-limiting gastroenteritis in humans, but in mice leads
to bacterial dissemination that is similar to the systemic infection that is observed in
humans infected with the related species Yersinia pestis—the causative agent of plague
[148, 151]. Y. pseudotuberculosis is a potent activator of caspase-8-dependent apoptosis in
macrophages [154, 173], and it was initially hypothesized that this induction of death
mediated virulence in infected mice. However, strains of Y. pseudotuberculosis that induce
less cell death in vitro have increased virulence in vivo [174], suggesting that caspase-8mediated apoptosis is a host-derived mechanism of limiting virulence and dissemination
of Y. pseudotuberculosis. These data suggest that caspase-8-medaited apoptosis is
protective in the context of oral Y. pseudotuberculosis infection.
In an effort to determine the role of caspase-8-mediated apoptosis in immune cells
during bacterial infection in vivo we generated bone marrow chimeras by transferring B6,
Ripk3-/-, and Ripk3-/-Casp8-/- bone marrow progenitors into sublethally C57BL/6 mice.
Consistent with the hypothesis that caspase-8-mediated apoptosis promotes host survival
we found that mice deficient in both RIPK3 and caspase-8, but not RIPK3 alone, had an
acute survival defect, and succumbed within 4-5 days of oral infection with
Y. pseudotuberculosis [75]. This survival defect correlated to increased bacterial burdens,
but we were surprised to discover that these mice had a marked impairment in cytokine
production [75]. We went on to show that caspase-8-deficient cells have a cell-intrinsic
defect in cytokine production in vivo, and caspase-8 was required for maximal cytokine
secretion in macrophages stimulated with multiple TLR ligands [75]. Surprisingly,
Ripk3-/-Casp8-/- macrophages had consistent defects in the transcription of the proinflammatory genes Il12b, Il1b, Il6 and Tnf among others [75].
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Other groups have begun to identify a role for caspase-8 in inflammatory cytokine
production as well. Ripk3-/-Casp8-/- mice have reduced IL-1β production during oral
infection with the gram-negative enteric pathogen Citrobacter rodentium [110]. Caspase8 mediates pro-IL-1β expression during in vitro infection with Salmonella typhimurium
[76], and mice infected with Yersinia pestis have defects in survival as well as
inflammatory cytokine release [100]. The observed cytokine-regulatory role of caspase-8
is not restricted to bacterial pathogens as pro-IL-1β expression is decreased in the absence
of caspase-8 during in vitro infection with the fungal pathogen Candida albicans [147].
However, the mechanism of caspase-8-mediated cytokine production in response to TLR
activation remains unclear. Caspase-8 is known to promote NF-κB-mediated pro-survival
gene expression in response to TNFR stimulation at the plasma membrane [84, 107].
However, the mechanism by which caspase-8 interacts with and signals from TLRs has yet
to be defined. TLR4 and TLR3 can signal through the adaptor protein TRIF which is known
to signal to caspase-8 in response to TLR4 activation [107], However, we also identified a
role for caspase-8 in response to MyD88-dependent TLRs such as TLR9, and there is no
reported interaction between caspase-8 and MyD88. Moreover, it is unclear if caspase-8
exerts it cytokine regulatory functions through the direct activation of NF-κB, indirect
activation through a cytoplasmic intermediate, or another activation of transcription factor.
To address these questions we first identified the repertoire of genes regulated by
caspase-8, and used promoter enrichment analysis to identify common transcription factor
binding motifs. We found that many of these motifs were annotated for NF-κB family
members, and that there was specifically impaired recruitment of c-Rel to the promoters of
caspase-8-dependent genes upon TLR4 stimulation in vitro. Moreover, c-Rel
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overexpression was sufficient to restore expression of IL-12 and IL-1β in caspase-8deficient cells. We also demonstrated that caspase-8 exerts this function though differential
IKK activation, and that the adaptor protein FADD was required for caspase-8-mediated
cytokine production in response to both MyD88 and TRIF dependent TLRs. These studies
provide insight into the divergent regulation of NF-κB proteins, and demonstrate an
indirect role for caspsase-8-dependent regulation of NF-κB nuclear translocation.
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2.3 Results
2.3.1 Caspase-8 regulates hundreds of inflammatory genes in response to TLR stimulation
that are enriched for NF-κB binding motifs.
Caspase-8 deficient cells have defects in inflammatory gene transcription in
response to both Myd88 and TRIF-dependent TLRs [75]. We sought to define the broad
transcriptional program regulated by caspase-8 by measuring total RNA 2 and 6hrs post
stimulation with the TLR4 and TLR9 agonists LPS and CpG respectively. We defined
caspase-8 dependent genes as those that were differentially affected by the absence of
caspase-8 (Fig 2.1A). Principle component analysis of our RNAseq data showed that
samples segregated by the type of TLR ligand (PCA1) which accounted for 58% of the
variance, and genotype was responsible for 8.8% of the variance (PCA2) (Fig 2.1B).We
had observed a strong effect of caspase-8 on the transcription of Il12b and Il1b in response
to LPS and CpG in previous in vitro experiments, but the repertoire of genes regulated by
caspase-8 was much more extensive. Caspase-8 regulated 371 and 537 LPS inducible genes
2 and 6 hours post stimulation respectively (Fig 2.1C). 388 and 316 CpG-inducible genes
were regulated 2 and 6 hours post stimulation respectively (Fig 2.1C). LPS is known to
induce approximately 2000 genes in macrophages [63]; therefore, in our hands, caspase-8
regulates approximately 25% of all LPS-inducible genes after stimulation.
Heat map analysis of caspase-8-dependent genes showed that many of these genes
were downregulated in the absence of caspase-8 at both 2 and 6hrs post LPS and CpG
stimulation (Fig 2.2A and Fig 2.2C). We performed gene ontology analysis (GO) with the
genes identified in each data set, and identified three distinct clusters of genes that were
caspase-8 dependent in both the LPS and CpG conditions. These clusters are highlighted

29

on the heat maps, and further characterized in panels 2.2B and 2.2D. There was a defect in
the induction of immune-regulated genes in response to both LPS and CpG in the absence
of caspase-8. Interestingly, there was also a defect in cell cycle gene expression in both
data sets as well. We performed promoter analysis to identify common transcription factor
binding motifs in the promoters of caspase-8-dependent genes at 6 hours post LPS and
CpG stimulation. We identified significant enrichment for NF-κB binding motifs which
was concordant with the GO analysis identifying cytokine and immune response genes in
the data set (Fig 2.2E). This data suggested that we would see a defect in overall NF-κB
signaling in caspase-8-deficient macrophages stimulated with both LPS and CpG.

2.3.2 Caspase-8 promotes IKK phosphorylation in response to TLR stimulation.
Upon TNFR stimulation caspase-8 indirectly regulates NF-κB signaling by cleaving the
K63 deubiquitinase CYLD to promote stable ubiquitination of RIPK1 [133]. Ubiquitinated
RIPK1 serves as a scaffold for IKKα, IKKβ, and IKKγ and mediates pro-survival gene
expression in response to TNF signaling[106]. However, it is unclear if caspase-8 signals
to NF-κB in response to TLR activation. Two kinases proximal to TLR stimulation are
TAK1—induced in response to MyD88-dependent TLRs—and TBK—induced in response
to TRIF-dependent TLRs. Using immunoblotting we were unable to identify any
differences in phosphorylation of TAK1 in response to both LPS and CpG (Fig 2.3A) and
TBK1 in response to LPS (Fig 2.3B). However, in caspase-8-deficient cells we consistently
saw a defect in phosphorylation of IKKα/IKKβ which is downstream of TAK1 activation
(Fig 2.3C). We observed enrichment for AP-1 family member transcription factor binding
motifs in our gene promoter analysis (data not shown). However, we did not observe a role
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for caspase-8 in MAPK activation measured through immunoblotting for phosphorylated
p38 (Fig 2.3D). We did not test other members of the MAPK signaling cascade
comprehensively, and this is a potential area of further investigation. From these data we
concluded that caspase-8 positively regulates IKK phosphorylation after TAK1 activation,
placing caspase-8 upstream of IKK phosphorylation and downstream of TAK1
phosphorylation.

2.3.3 Caspase-8 promotes IκBε degradation in response to TLR4 stimulation.
NF-κB proteins are expressed in the cytoplasm as homo- and hetero-dimers [69].
IκB family members are bound to NF-κB proteins preventing their nuclear translocation
until IκB proteins are phosphorylated and targeted for proteasomal degradation [175]. The
observed requirement for caspase-8 in maximal IKKα/IKKβ phosphorylation suggested
that caspase-8 would also indirectly regulate IκB protein degradation. We measured
degradation of three IκB proteins (IκBα, IκBβ, and IκBε) in response to LPS and CpG.
There was a slight, but consistent defect in IκBε degradation in response to LPS (Fig 2.4A
and Fig 2.4B), and no defect in either IκBα or IκBβ (Fig 2.4A and Fig 2.4C). This was
surprising given the profound defect we observed in IKKα/IKKβ phosphorylation in the
absence of caspase-8. It is possible that IκBε is more sensitive to levels of phospho-IKK
than other IκB proteins, or that the assays we used were not sensitive enough to measure
small differences in degradation in the case of IκBα and IκBβ. The reported role for IκBε
in the regulation of the NF-κB family members c-Rel and p65 [176] prompted us to
investigate if there were measurable differences in nuclear translocation of these
transcription factors in the absence of caspase-8.
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2.3.4 Caspase-8 promotes c-Rel nuclear translocation in response to TLR4 and TLR9
stimulation.
Our previous observation that caspase-8 promoted IKK phosphorylation provoked
the hypothesis that caspase-8 may exert its cytokine regulatory function through activation
of the NF-κB family members c-Rel and p65. To test this hypothesis we used
immunoblotting to measure the amount of c-Rel and p65 in nuclear enriched fractions of
B6, Ripk3-/-, and Ripk3-/-Casp8-/- macrophages. We observed a defect in c-Rel translocation
in response to both LPS and CpG—albeit slightly less so in response to CpG—and
equivalent levels of p65 in nuclear fractions of B6 and Ripk3-/-Casp8-/- macrophages (Fig
2.5A and Fig 2.5B). One possible interpretation of these data is that caspase-8 regulates
overall c-Rel expression through its gene regulatory function, but we observed no
difference in basal or inducible c-Rel levels in B6, Ripk3-/-, and Ripk3-/-Casp8-/macrophages (Fig 2.5C). We then used confocal microscopy to directly quantify c-Rel
nuclear translocation on a single-cell basis (Fig 2.5E). There was a consistent, and
measurable defect in c-Rel translocation in Ripk3-/-Casp8-/- macrophages stimulated with
both LPS and CpG (Fig 2.5D, Fig 2.5E, and Fig 2.5F). We consistently observed that CpG
stimulation revealed a smaller defect than LPS stimulation, which can likely be attributed
to the relative intensity of both stimuli. LPS stimulation appears to induce a larger and
more rapid response in wild type macrophages when compared to CpG stimulation;
therefore, the magnitude of the response to LPS stimulation creates a larger dynamic range
in which we can observe the effect of caspase-8 on the maximal response to TLR stimuli.
These data suggested that caspase-8 regulates inflammatory gene expression through the
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NF-κB family member c-Rel specifically. These data were surprising given that c-Rel is
only reported to be required for Il12b expression in macrophages, and our transcriptional
analysis implicated caspase-8 in the regulation of hundreds of LPS-and CpG-inducible
genes. We next sought to determine if the defect in c-Rel translocation correlated with a
measurable difference in recruitment to the promoters of caspase-8-depenent genes.

2.3.5 Caspase-8 promotes c-Rel recruitment to the promoters of caspase-8-dependent
genes.
B6, Ripk3-/- and Ripk3-/-Casp8-/- macrophages have equivalent levels of p65 bound
to the promoters of several caspase-8-dependent genes (Il12b, Il1b, Tnf, and Il6) after LPS
stimulation (Fig 2.6A). These data are concordant with our observation that caspase-8 has
no impact on p65 nuclear translocation in response to TLR4 stimulation. We did observe a
defect in c-Rel recruitment to the promoters of Il12b, Il1b, Tnf, and Il6 after LPS
stimulation (Fig 2.6A). Moreover, this defect occurred within 30 minutes LPS stimulation
(Fig 2.6B). These data demonstrated that caspase-8 may mediate divergent regulation of
p65 and c-Rel in response to TLR activation, as caspase-8 appears to be dispensable for
p65 translocation, but not for c-Rel translocation. Given previous reports identifying a
limited role for c-Rel in Il12b expression we next tested the requirement for c-Rel in
transcription of other caspase-8-dependent genes.

2.3.6 c-Rel regulates several caspase-8-dependent genes in response to TLR stimulation.
Utilizing Rel-/- macrophages we sought to assess the role for c-Rel in the regulation
of caspase-8-dependent genes. The expression of several inflammatory genes in addition
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to Il12b were decreased in Rel-/- macrophages stimulated with both LPS and CpG (Fig
2.7A). This provided evidence that c-Rel was required for the expression of other
inflammatory genes in addition to Il12b. We also observed a decrease in pro-IL-1β
expression in the absence of c-Rel in response to both LPS and CpG which could be
measured on a per cell basis (Fig 2.7B) as well using a bulk assay (Fig 2.7C). Surprisingly,
we observed an increase in IL-6 secretion in Rel-/- macrophages stimulated with LPS
despite the decrease we observed transcriptionally, and we observed no difference in TNF
secretion between B6 and Rel-/- macrophages (Fig 2.7D). This suggested that although
c-Rel regulates gene expression of several caspase-8-dependent genes there may be a
threshold of transcript that is sufficient to mediate wild-type levels of cytokine secretion.
There was a role for c-Rel in both the expression of Il1b and production of pro-IL-1β,
which had not been previously identified. These data suggested that we could bypass the
requirement for caspase-8 in IL-12p40 and pro-IL-1β production through the expression of
c-Rel in caspase-8-deficient macrophages.

2.3.7 c-Rel expression restores IL-12p40 and pro-IL-1β expression in caspase-8-deficient
macrophages.
We expressed c-Rel containing an IRES-GFP in macrophages lacking caspase-8.
The inefficiency of this transfection created an internally controlled experiment by which
we could measure the impact of c-Rel expression on a per-cell basis in cells expressing
GFP compared to those that were GFP negative. Cells that are successfully transfected can
be identified through GFP expression using flow cytometry (Fig 2.8A). After 6 hours the
plasmid is expressed in approximately 30% of cells (Fig 2.8A and Fig 2.8B). We then used
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intracellular cytokine staining with this mixed population of GFP+ and GFP- cells to
determine if cell-intrinsic expression of c-Rel restored IL-12p40 and pro-IL-1β in
individual cells. We found that expression of c-Rel restored IL-12p40 expression in
Ripk3-/-Casp8-/- macrophages in the absence of stimulation as well as in response to LPS
and CpG (Fig 2.9A). The expression of IL-12p40 in the absence of TLR activation may be
due to the lack of co-expression of the negative regulator IκBε, meaning all plasmidderived c-Rel is able to translocate directly into the nucleus. Interestingly, only LPS
stimulation coupled with c-Rel expression was sufficient to restore pro-IL-1β expression
in the absence of caspase-8 (Fig 2.9B). These data suggest that another transcription factor
synergizes with c-Rel to induce Il1b expression during CpG stimulation. It is also possible
that a larger amount of c-Rel is required for induction of pro-IL-1β which is supported in
part by the pronounced defect in pro-IL-1β in Rel-/- macrophages. The increase in IL-12p40
and pro-IL-1β observed in Ripk3-/-Casp8-/- macrophages transfected with c-Rel was
equivalent to expression observed in Ripk3-/- macrophages transfected with empty plasmid
(Fig 2.10A and Fig 2.10B). This indicated that c-Rel expression in caspase-8-deficient
cells was sufficient to restore IL-12p40 and pro-IL-1β expression to wild-type levels. These
data collectively demonstrate that caspase-8 regulates Il12b and Il1b through the NF-κB
family member c-Rel. This regulatory function seemed to be mediated indirectly through
caspase-8-dependent activation of IKK. We next sought to define the adaptor proteins that
coupled TLR activation to caspase-8.
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2.3.8 Caspase-8 is coupled to TLR activation through the adaptor protein FADD.
The adaptor protein FADD is known to promote recruitment of caspase-8 to TNFR
[84] which led us to hypothesize that it might play a similar role in response to TLR
activation. Single ablation of FADD leads to the induction of programed necrosis in
response to macrophage stimulation, but these cells can be rescued when proteins required
for programmed necrosis are also ablated [160]. Therefore, we tested the role of the adaptor
protein FADD in promoting IKK activation in response to TLR4 and TLR9 stimulation
using Fadd-/-Mlkl-/- macrophages which cannot undergo programmed necrosis. We
observed a defect in IKKα/IKKβ phosphorylation in Fadd-/-Mlkl-/- macrophages in
response to both LPS and CpG stimulation (Fig 2.11A and Fig 2.11B). FADD-deficiency
also leads to a decrease in IκBε degradation in response to both LPS and CpG (Figure
2.11C). Fadd-/-Mlkl-/- macrophages had a decrease in the transcription of Il12b, Il1b, and
Il1a (Fig 2.11D) as well as the secretion of IL-12p40, TNF and IL-6 (Fig 2.11E). These
data suggest that caspase-8 may be coupled to the activation of both MyD88 and TRIF
dependent TLRs through FADD, although, the effects we observed in the absence of
caspase-8 are even more stark in the absence of FADD. It is possible that FADD interacts
with other signaling molecules that mediate inflammatory gene expression in addition to
caspase-8. Moreover, these data are also preliminary as the experiments depicted in panels
2.11C and 2.11D have only been performed once due to reagent limitations. However, the
consistent impact of FADD on cytokine secretion and IKK phosphorylation suggests that
this adaptor may be the mechanism by which caspase-8 is activated in response to TLR
stimulation, although further studies are required.
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2.4 Discussion
Previous work has demonstrated a critical role for caspase-8 in apoptosis,
programmed necrosis, and cytokine expression [76, 102, 105, 125]. Here we define a
mechanism by which caspase-8 regulates Il1b and Il12b via the NF-κB family member cRel (Fig 2.12). Caspase-8 promotes IKK phosphorylation which in turn induces IκBε
degradation, c-Rel translocation, and c-Rel recruitment to the promoters of Il12b and Il1b.
Despite our observation that caspase-8 regulates hundreds of LPS- and CpG-inducible
genes, it appears that c-Rel is only required for expression of Il12b and Il1b. Therefore,
there are likely other mechanisms of caspase-8-dependent inflammatory gene regulation
that we have yet to identify. LPS and CpG promote expression of both overlapping, and
distinct subsets, of caspase-8-depenent genes, suggesting that there is likely there is a
common signaling mechanism for caspase-8 in response to both TLRs as well as TLR4
and TLR9 specific regulation that is also caspase-8 dependent.
Caspase-8-mediated c-Rel translocation appears to be specifically dependent on the
sensitivity of IκBε to lower levels of IKK phosphorylation. Despite the strong decrease we
observed in IKK phosphorylation, in the absence of caspase-8, IκBα and IκBβ degradation
are indistinguishable from that observed in wild-type macrophages (Fig 2.4). There are
studies demonstrating divergent temporal regulation of IκB proteins over the course of
cellular activation [59], but it appears another mechanism of regulation may be differential
sensitivity upstream kinases. The role of caspase-8 in the divergent regulation of p65 and
c-Rel was also surprising. p65 and c-Rel are largely thought to be redundant during TLR
activation in macrophages apart from the requirement for c-Rel in Il12b transcription [71].
However, our data suggest that c-Rel plays an important role in the expression of both
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IL-12p40 and IL-1 family cytokines, offering a potential explanation for recent studies that
have observed a role for caspase-8 in inflammasome priming via the induction of pro-IL1β [76, 77, 111].
The mechanisms that govern disparate regulation of p65 and c-Rel in the cytoplasm
have yet to be defined. Recent work has identified a novel cellular nucleic acid binding
protein (CNBP) that is required for c-Rel translocation during TLR activation, but
dispensable for p65 [24]. We did not observe a defect in CNBP enrichment in nuclear
fractions of Ripk3-/-Casp8-/- macrophages (data not shown), but our data suggest that
caspase-8 may be another cytoplasmic factor that bifurcates p65 and c-Rel activation. We
observed that c-Rel expression was sufficient to restore IL-12p40 production to wild-type
levels in untreated as well as LPS and CpG stimulated cells (Fig 2.9A and Fig 2.10A);
however, only LPS stimulation restored pro-IL-1β production (Fig 2.9B). This was
surprising given the defect in pro-IL-1β production in Rel-/- macrophages stimulated with
both LPS and CpG (Fig 2.7B). It is possible that there was insufficient c-Rel to restore proIL-1β production, or perhaps there is another regulatory factor that synergizes with c-Rel
in this context.
Our preliminary data suggest a role for the adaptor protein FADD in activation of
caspase-8 in response to TLR stimulation. This data is intriguing given that FADD is
known to collaborate with caspase-8 during activation of death receptors [89, 112, 177].
FADD appears to promote IKK phosphorylation in response to TRIF- and MyD88dependent TLRs which was surprising given recent work showing that MyD88 is
dispensable for programed necrosis induced in response to TLR4 stimulation and caspase8 inhibition [107]. However, it is possible that MyD88 interacts directly with FADD in the
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context of TLR signaling under pro-survival conditions. The protein structure of FADD
may shed light on the mechanism of collaboration between TRIF, MyD88, caspase-8 and
FADD. FADD contains a death effector domain which can recruit caspase-8 via homotypic
interactions. TRIF contains a region annotated for “sufficient to induce apoptosis”
suggesting this might promote an interaction with FADD. Finally, MyD88 contains a death
domain that could mediate a direct interaction with the death domain of FADD. Therefore,
FADD may facilitate caspase-8 recruitment downstream of death receptors as well as
TLRs. However, more mechanistic investigations are required to define the role of FADD
in caspase-8-mediated cytokine expression.
In this chapter we have defined a mechanism for the regulation of Il12b and Il1b
transcription by caspase-8. In Chapter 3 we will interrogate the role of caspase-8
enzymatic activity in this system.
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2.5 Figures

Fig 2.1. Caspase-8 regulates hundreds of genes in response to TLR stimulation.
(A) Diagram of RNAseq analysis experimental design.
(B) Principal component analysis of transcriptional profiling data from untreated or 2hrs
post-LPS- or CpG-treatment of B6, Ripk3-/-, and Ripk3-/-Casp8-/- BMDMs.
(C) Total number of caspase-8-dependent genes at 2 and 6 hours post LPS or CpG
stimulation. Venn diagrams demonstrating the overlap of caspase-8-dependent genes in
both the LPS- and CpG-treated BMDMs.
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Fig 2.2 Caspase-8 regulates inflammatory genes that are enriched for NF-κB binding
motifs.
(A, C) Heat maps of the global transcriptional response of B6, Ripk3-/-, and
Ripk3-/-Casp8-/- BMDMs 2 or 6 hours post stimulation with either LPS (A) or CpG (C).
Gene clusters containing caspase-8-dependent genes following LPS or CpG stimulation
are numbered and indicated with a sidebar to the right of each heat map.
(B, D) Bubble plot representation of gene ontology enrichment analyses on caspase-8dependent gene clusters shown in (A) and (C). Bubble color indicates the degree to which
genes associated with each term were upregulated (red) or downregulated (blue). Bubble
size represents the number of genes within a cluster that were associated with each term.
(E) HOMER gene promoter analysis of caspase-8-dependent genes 6 hours post LPS or
CpG stimulation.
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Fig 2.3 IKK phosphorylation is caspase-8-dependent in response to TLR stimulation.
(A) Immunoblots of phospho-TAK1 and total TAK1 in B6, Ripk3-/-, and Ripk3-/-Casp8-/BMDMs following stimulation with LPS or CpG for indicated times.
(B) Immunoblots of phospho-TBK1 and total TBK1 in B6, Ripk3-/-, and Ripk3-/-Casp8-/BMDMs following stimulation with LPS for indicated times.
(C) Immunoblots of phospho-IKKα/β and total IKKβ in B6, Ripk3-/-, and Ripk3-/-Casp8-/BMDMs following stimulation with LPS or CpG for indicated times.
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Fig 2.3 Continued: (D) Immunoblots of phospho-p38 and total p38 in B6, Ripk3-/-, and
Ripk3-/-Casp8-/- BMDMs following stimulation with LPS or CpG for indicated times.
(A-B) Representative of two independent experiments. (C-D) Representative of three
independent experiments.
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Fig 2.4 TLR4-induced IκBε degradation is impaired in the absence of caspase-8.
(A) Immunoblots of IkBε and IkBα in B6, Ripk3-/-, and Ripk3-/-Casp8-/- BMDMs stimulated
with LPS or CpG.
(B) Quantification of immunoblots of IkBε in Ripk3-/- and Ripk3-/-Casp8-/- BMDMs
stimulated with LPS or CpG for 2hrs.
(C) Immunoblots of IkBβ in B6, Ripk3-/-, and Ripk3-/-Casp8-/- BMDMs stimulated with
LPS.
Student’s two-tailed paired t-test, * p<0.05. Data are representative of at least three
independent experiments.
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Fig 2.5 Caspase-8 promotes c-Rel translocation independently of p65.
(A) Immunoblots of c-Rel in nuclear fractions of Ripk3-/- and Ripk3-/-Casp8-/- BMDMs
following LPS or CpG stimulation for indicated times.
(B) Immunoblots of p65 in nuclear fractions of B6, Ripk3-/- and Ripk3-/-Casp8-/- BMDMs
following LPS or CpG stimulation for indicated times.
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Fig 2.5 Continued: (C) Total c-Rel expression in B6, Ripk3-/-, and Ripk3-/-Casp8-/BMDMs stimulated with LPS or CpG for the indicated times.
(D) Quantification of the ratio of mean fluorescence intensity of nuclear:cytoplasmic c-Rel
in Ripk3-/- and Ripk3-/-Casp8-/- BMDMs stimulated with LPS; box plots represent 60-150
individual cells per condition, Box plots indicate the median, upper and lower quartiles,
and upper and lower extremes of the data.
(E) Quantification of the ratio of mean fluorescence intensity of nuclear:cytoplasmic c-Rel
in Ripk3-/- and Ripk3-/-Casp8-/- BMDMs stimulated with LPS or CpG; each datapoint
indicates the mean of an individual experiment; Student’s two-tailed paired t-test, * p<0.05.
(F) Representative confocal images of experiment quantified in (D, E); B6, Ripk3-/- and
Ripk3-/-Casp8-/- BMDMs stimulated with LPS or CpG for 2hrs; c-Rel, actin and DAPI
pseudo-colored in green, white and blue respectively.
Student’s two-tailed unpaired t-test (n.s. not significant, **** p<0.0001). All data
representative of at least three independent experiments.
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Fig 2.6 Caspase-8 promotes c-Rel recruitment to the promoters of caspase-8-dependent
genes.
(A) ChIP-qPCR measuring fold-enrichment of p65 and c-Rel at the promoters of Il12b,
Il1b, Il6, and Tnf 2hrs post LPS stimulation.
(B) Fold-enrichment of c-Rel at indicated cytokine gene promoters in Ripk3-/- and
Ripk3-/-Casp8-/- BMDMs following LPS treatment was determined by ChIP-qPCR at
indicated times post-stimulation.
Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05, ** p<0.01, *** p<0.001,
**** p<0.0001). Error bars indicate ± SEM of triplicates. All data representative of at least
three independent experiments.
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Fig 2.7 c-Rel regulates both IL-12p40 and pro-IL-1β expression in response to TLR
activation.
(A) Fold-change in indicated inflammatory response genes in B6 and Rel-/- BMDMs 2hrs
post-stimulation with LPS or CpG, as indicated.
(B) Flow-cytometry quantification and (C) immunoblot of intracellular pro-IL-1β
expression in B6 and Rel-/- BMDMs stimulated with LPS or CpG for 6hrs.
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Fig 2.7 Continued: (D) ELISA measurement of secreted IL-12p40, IL-6, and TNF in B6
and Rel-/- BMDMs following stimulation with LPS or CpG for 6hrs.
Student’s two-tailed unpaired t-test (n.s. not significant, ** p<0.01, *** p<0.001, ****
p<0.0001). Error bars indicate ± SEM of triplicates. All data representative of at least three
independent experiments.
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Fig 2.8 hc-Rel-IRES-GFP is expressed robustly in primary macrophages.
(A) Transfection schematic diagram indicating nucleofection of hc-Rel-IRES-GFP plasmid
into primary BMDMs, and representative flow cytometry data indicating transfection
efficiency measured 6hrs post-transfection.
(B) GFP expression was assayed in B6, Ripk3-/- and Ripk3-/-Casp8-/- BMDMs 6, 12 and
24hrs post-transfection.
Data are representative of three independent experiments.
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Fig 2.9 hc-Rel expression restores both IL-12p40 and pro-IL-1β production in the absence
of caspase-8.
(A) Flow cytometry of intracellular IL-12p40 and (B) pro-IL-1β in Ripk3-/-Casp8-/BMDMs transfected with an IRES-GFP-expressing empty vector or hc-Rel-IRES-GFPexpressing plasmid and stimulated with LPS or CpG for 4hrs.
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Fig 2.9 Continued: Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05, ***
p<0.001). Error bars indicate ± SEM of triplicates. All data representative of at least three
independent experiments.
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Fig 2.10 In the absence of caspase-8 hc-Rel expression restores both IL-12p40 and pro-IL1β to levels observed in Ripk3-/- cells.
(A) Frequency of intracellular IL-12p40+ or (B) pro-IL-1β+ Ripk3-/- or Ripk3-/-Casp8-/BMDMs transfected with hc-Rel-IRES-GFP-expressing plasmid and stimulated with LPS
or CpG for 4hrs.
Each data point represents the mean frequency of positive cells within an individual
experiment. Lines link genotypes within the same experiment Student’s paired two-tailed
t-test (n.s. not significant).
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Fig 2.11 FADD promotes inflammatory gene expression and IKK phosphorylation in
response to TLR activation.
(A, B) Immunoblot of phospho-IKKα/β and total IKKβ in Mlkl-/- and Mlkl-/-Fadd-/- BMDMs
stimulated with LPS (A) and CpG (B) for indicated times.
(C) Immunoblots of IkBε in Mlkl-/- and Mlkl-/-Fadd-/- BMDMs stimulated with LPS or CpG
for the indicated times.
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Fig 2.11 Continued: (D) RT-qPCR of caspase-8-dependent genes in Mlkl-/- and
Mlkl-/-Fadd-/- BMDMs stimulated with LPS or CpG for 2hrs.
(E) ELISA of secreted IL-12p40, IL-6, and TNF in Mlkl-/- and Mlkl-/-Fadd-/- BMDMs
stimulated with LPS or CpG for 6hrs.
Experiments representative of one (C, D) or two (A, B, E) independent experiments. Error
bars indicate ± SEM of triplicates. Student’s two-tailed unpaired t-test (n.s. not significant,
* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001).
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Fig 2.12 Graphical abstract and future directions: Caspase-8 promotes Il12b and Il1b
expression through c-Rel.

57

CHAPTER 3: Caspase-8 enzymatic activity promotes inflammatory
gene expression in macrophages.
3.1 Abstract
Caspase-8 enzymatic activity is required for its apoptotic function and for the
repression of programmed necrosis; however, it is unclear if this activity is required for its
role in cell-intrinsic inflammatory gene expression. Others have shown that ablation of
caspsase-8 expression impairs inflammatory gene expression and inflammasome priming.
Data from our lab suggest a role for caspase-8 enzymatic activity in macrophage TLR
activation, but others have found that caspase-8 scaffolding is sufficient to mediate gene
expression in response to TRAIL stimulation. Using both genetic and chemical approaches
we identify a role for both caspase-8 enzymatic and non-enzymatic activity in response to
TLR activation. We show that caspase-8 is enzymatically active in response to both TLR4
and TLR9 stimulation, and that inhibition of caspase-8 reduced the production of IL-12p40
and IL-1β. We also demonstrate that caspase-8 enzymatic activity promotes IKK
phosphorylation and c-Rel nuclear translocation—one mechanism that we have identified
for caspase-8-mediated inflammatory gene regulation. These experiments demonstrate a
role for the enzymatic activity of caspase-8 in inflammatory gene expression in response
to TLR activation, adding to our understanding of the diverse functions of caspase-8 in
macrophages.
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3.2 Introduction
Caspase-8 regulates two forms of cell death: apoptosis [102] and programmed
necrosis [133]. In the context of apoptotic stimuli such as TNF or FasL caspase-8 is
recruited to the death inducing signaling complexes (DISC) via its death effector domain
[82, 85]. Apoptotic signals induce caspase-8 homodimerization, whereby each monomer
undergoes auto-processing, and forms two catalytic sites that mediate cleavage of its
apoptotic substrates [79, 80, 113]. Caspase-8 is also enzymatically active in heterodimers
formed with a homologous protein cFLIP, as this enzymatic activity is required for the
inhibition of programmed necrosis. Caspase-8 enzymatic activity under pro-survival and
pro-apoptotic conditions is required for the cleavage of substrates that mediate
programmed necrosis such as the K63 linear deubiquitinase CYLD [105]. It is
hypothesized that caspase-8/cFLIP heterodimers are constitutively present under prosurvival conditions, and that caspase-8 monomers do not form stable catalytic sites without
the presence of cFLIP [105]. Under pro-survival conditions caspase-8/cFLIP heterodimers
mediate cleavage of CYLD, this cleavage promotes ubiquitination of RIPK1 (Receptor
Interacting Serine/Threonine Kinase 1) which serves as a scaffold for the recruitment of
IKKγ, and activation of NF-κB proteins to promote transcription of pro-survival genes
[106]. Chemical or pathogen mediated blockade of NF-κB signaling leads to the downregulation of cFLIP expression and induction of apoptosis [178-180].
Our group as well as other have demonstrated another role for caspase-8 in the cellintrinsic expression of inflammatory cytokines [75, 77, 100]; however, the role of caspase8 enzymatic activity in this context has yet to be resolved. We have demonstrated that both
chemical inhibitors of caspase-8 catalytic activity and inhibition of cFLIP expression
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impairs cytokine secretion in macrophages stimulated with TLR agonists [75]. These data
support a model in which caspase-8 enzymatic activity mediates inflammatory gene
expression. However, work from others has shown that caspase-8 scaffolding is sufficient
to induce NF-κB activation in response to TRAIL (Tumor necrosis factor related apoptosis
inducing ligand) stimulation in HeLa cells [112]. These models are not mutually exclusive
as it is possible that there are cell-specific and stimuli-specific functions of caspase-8.
We utilized two approaches in an effort to elucidate the function of caspase-8
enzymatic activity in the context of gene expression. The first being chemical inhibition of
caspase-8 catalytic activity in Ripk3-/- macrophages as well as macrophages derived from
mice in which we ablated caspase-8-dependent apoptosis, but preserved its cytokine
regulatory function. These mice express caspase-8 with a mutation in the linker region that
mediates stabilization of the apoptotic conformation of caspase-8 [80, 113]. We refer to
these mice, and cells derived from them, as Casp8DA/DA. Our characterizations of these mice
will be described in Chapter 4: briefly, macrophages from these mice are unable to
undergo caspase-8 dependent apoptosis in response to Yersinia pseudotuberculosis (Yp)
infection, but secrete wild-type levels of inflammatory cytokines in response to TLR
stimulation [75]. We have crossed these mice with Ripk3-/- mice to eliminate the impact of
programmed necrosis in this system: we refer to mice, and cells derived from them ,as
Ripk3-/-Casp8DA/DA. In this chapter we seek to elucidate the role of the pro-survival
conformation of caspase-8 on inflammatory gene expression as well as the enzymatic
requirements for this function.
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3.3. Results
3.3.1 TLR stimulation promotes caspase-8 catalytic activity.
We have previously shown that inhibition of caspase-8 catalytic activity reduced
inflammatory cytokine secretion, but it is possible that this was mediated by off-target
effects of these chemical compounds [75]. Therefore, we sought to directly test the
activation of caspase-8 in response to TLR stimulation. Previous groups have shown that
TLR4 stimulation promotes the cleavage of the linear deubiquitinase CYLD [107]. We
found that caspase-8 catalytic activity was induced in response to both LPS and CpG in
Ripk3-/- macrophages within 30 min of stimulation (Fig 3.1A). Interestingly, this activation
was not to the same magnitude as that observed with the apoptotic stimulus staurosporine
(Fig 3.1A). All caspase-8 activation was blocked by the pan-caspase inhibitor zVAD;
therefore, we concluded that our previous findings demonstrating a role for caspase-8 in
inflammatory cytokine secretion were likely not due to off target effects of zVAD
(Fig 3.1A). We also found that CYLD was cleaved in response to LPS stimulation, and
that this cleavage was partially blocked using both zVAD and the caspase-8-specific
inhibitor IETD (Fig 3.1B). These data demonstrate that caspase-8 activity is induced in
response to TLR activation, and that chemical inhibition—using zVAD or IETD—is
sufficient to block a majority of caspase-8 activity.

3.3.2 Caspase-8 enzymatic activity promotes inflammatory gene expression and IKK
phosphorylation.
We measured transcription of several caspase-8-dependent genes (described in
Chapter 2) in Ripk3-/- macrophages stimulated with the TLR4 and TLR9 agonists LPS and

61

CpG respectively. zVAD inhibition reduced expression of Il12b in response to LPS but not
CpG (Fig 3.2A). This result was surprising given the defect we observed in IL-12p40
secretion in LPS- and CpG-stimulated Ripk3-/- macrophages treated with zVAD (Fig 3.2B).
Moreover, zVAD treatment was not sufficient to decrease LPS-induced Il12b transcription
to the same magnitude as ablation of caspase-8, but it appears this was sufficient to reduce
IL-12p40 secretion to similar levels observed in Ripk3-/-Casp8-/- macrophages (Fig 3.2A
and Fig 3.2B). These data suggest that there is a threshold of Il12b transcript required for
secretion of IL-12p40, and the decrease we observed in the context of zVAD inhibition is
sufficient to reduce cytokine secretion to levels observed in Ripk3-/-Casp8-/- macrophages.
There was a similar trend in the expression of Il1b in LPS-stimulated cells: zVAD
treatment impaired transcription, and this reduction was sufficient to reduce pro-IL-1β
expression to levels observed in Ripk3-/-Casp8-/- macrophages (Fig 3.2A and Fig 3.2B). We
measured a decrease in transcription of Il1a and Il4i1 in LPS-stimulated Ripk3-/macrophages treated with zVAD, but again this decrease was not to the same magnitude
as caspase-8 ablation. There was no role for caspase-enzymatic activity in the transcription
of Il1a or Il4i1 in response to CpG which is consistent with what we observed for Il12b
and Il1b (Fig 3.2A).
We interpret these data to mean that both caspase-8 enzymatic activity and
scaffolding play a role in inflammatory gene expression, but the role of each appears to be
gene and TLR-dependent. There seems to be more of a requirement for caspase-8
enzymatic activity in response to TLR4 stimulation, but it seems to be dispensable in some
contexts in response to CpG. Based on these data we expected to observe a role for caspase8 enzymatic activity in the phosphorylation of IKK in response to LPS, and not CpG, but
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we were surprised to find zVAD treatment reduced IKK phosphorylation in both contexts
(Fig 3.2C). It is possible that NF-κB-dependent genes display differing levels of sensitivity
to IKK phosphorylation as we do not see a defect in transcription of Il12b, Il1a, and Il4i1
in CpG-stimulated macrophages treated with zVAD (Fig 3.2A). One possible explanation
is that the use of a pan-caspase inhibitor masked caspase-8-specific enzymatic
requirements; therefore, we sought to test the impact of the caspase-8-specific inhibitor
IETD on gene transcription.

3.3.3 Caspase-8 enzymatic activity promotes Il12b transcription and IL-12p40 secretion.
Consistent with our previous observations, Ripk3-/- macrophages treated with IETD
have decreased IL-12p40 secretion in response to LPS (Fig 3.3A). We also discovered this
was the case in response to CpG stimulation, again, suggesting a role for caspase-8
enzymatic activity in IL-12 secretion in response to both LPS and CpG (Fig 3.3A).
Surprisingly, IETD reduced Il12b transcription in response to both LPS and CpG to the
same magnitude as that observed in Ripk3-/-Casp8-/- macrophages (Fig 3.3B). We interpret
these data to mean that caspase-8 enzymatic activity is required for transcription of Il12b,
and corresponding secretion of IL-12p40 in response to TLR activation. It is possible that
because zVAD targets other caspases it is not sufficient to block all caspase-8 activity, but
we could observe no measurable caspase-8 activity in our previous assay in Ripk3-/macrophages treated with zVAD (Fig 3.1A). Based on our observations that caspase-8
catalytic activity mediated inflammatory gene expression and IKK phosphorylation we
hypothesized that we would observe a decrease in c-Rel nuclear translocation in zVADtreated cells (based on findings discussed in Chapter 2).
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3.3.4 Caspase-8 enzymatic activity promotes c-Rel nuclear translocation.
We quantified nuclear translocation of c-Rel using single-cell analysis of Ripk3-/macrophages treated with zVAD then stimulated with LPS or CpG. Consistent with the
observed role for caspase-8 enzymatic activity on gene expression, zVAD treatment
reduced c-Rel translocation (Fig 3.4B).. However, this reduction was not to the same
magnitude as that observed in observed in Ripk3-/-Casp8-/- macrophages (Fig 3.4B).
Ripk3-/- macrophages treated with zVAD have much less nuclear c-Rel when compared to
vehicle-treated cells stimulated with LPS or CpG. We interpret these data to mean that
caspase-8 enzymatic activity promotes c-Rel translocation in response to both TLR4 and
TLR9 agonists, but caspase-8 scaffolding also contributes to c-Rel translocation in this
context. We next sought to determine if enzymatically inactive caspase-8 recapitulated our
observations with Ripk3-/- macrophages treated with chemical inhibitors of caspase-8
activity.

3.3.5 Caspase-8 enzymatic activity promotes cytokine secretion.
We transduced wild-type caspase-8 (Casp8WT), catalytically inactive caspase-8
(Casp8D3A), and an empty vector into Ripk3-/-Casp8-/- immortalized macrophages
(Fig 3.5A). Each construct also expressed GFP allowing us to enrich for transduced cells
after puromycin selection, resulting in an approximately 95% pure population (data not
shown). We observed that cells expressing catalytically inactive caspase-8 had reduced
secretion of TNF in response to both LPS and CpG; however, not to the magnitude
observed in our empty vector controls expressing no caspase-8 (Fig 3.5B). These data are
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consistent with our observations in primary Ripk3-/- macrophages treated with zVAD in
which there are enzymatic and non-enzymatic contributions of caspase-8. One question
raised by these data was whether some low-level of caspase-8 homodimers contribute to
the observed requirement for caspase-8 enzymatic activity without causing measurable cell
death.

3.3.6 Caspase-8 non-apoptotic activity mediates inflammatory cytokine expression and
IKK phosphorylation.
It is hypothesized that caspase-8 homodimers do not form under pro-survival
conditions, but it is formally possible that both caspase-8/cFLIP heterodimers and
caspase-8 homodimers are present in Ripk3-/- macrophages under these conditions. To
address this question we utilized macrophages in which caspase-8 apoptotic activity is
inactive, but the protein is expressed and maintains catalytic activity (Casp8DA/DA).
Casp8DA/DA macrophages expressed Il12b to the same extent as B6 macrophages stimulated
with LPS (Fig 3.6A). IKK phosphorylation in Casp8DA/DA macrophages was
indistinguishable from B6 macrophages stimulated with LPS (Fig 3.6B). These data were
consistent with our previous report that Casp8DA/DA macrophages produced cytokines to the
same magnitude as B6 cells [75]. We have previously found no role for RIPK3 in gene
expression, but we generated macrophages from Ripk3-/-Casp8DA/DA to formally test the
role for programed necrosis in this context. Surprisingly, we found that LPS-stimulated
Ripk3-/-Casp8DA/DA macrophages expressed Il12b to a higher magnitude than Ripk3-/-Casp8/-

cells, but not to the same extent as Ripk3-/- cells (Fig 3.6C). This was concordant with the

intermediate level of IKK phosphorylation observed in Ripk3-/-Casp8DA/DA macrophages
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stimulated with LPS (Fig 3.6E). However, Ripk3-/-Casp8DA/DA macrophages secreted IL12p40 equivalently to Ripk3-/- macrophages in response to LPS stimulation (Fig 3.6D).
These data are similar to our previous observations that defects in cytokine gene
transcription cannot be directly correlated to cytokine protein secretion. It is possible that
despite the observed reduction in Il12b transcription, in Ripk3-/-Casp8DA/DA macrophages
stimulated with LPS, there was enough transcript to mediate wild-type levels of IL-12p40
secretion.
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3.4 Discussion
Here we describe a role for caspase-8 enzymatic activity in inflammatory gene
transcription in macrophages. Moreover, we were able to directly measure catalytic activity
of caspase-8 in response to the Myd88-dependent TLR9. This was surprising given that
there is limited data suggesting that caspase-8 can be activated downstream of MyD88. In
support of a model in which MyD88 activates caspase-8, we observed defects in IKK
phosphorylation, and c-Rel translocation in response to CpG stimulation (discussed in
Chapter 2), and here we report that this defect is in part due to the absence of caspase-8
catalytic activity. We also report for the first time that there is a defect in inflammatory
cytokine secretion when caspase-8 catalytic activity is blocked in CpG-stimulated cells.
The role for caspase-8 enzymatic activity is less clear with regards to CpG-induced gene
transcription, as we cannot observe a decrease in transcription of Il12b, Il1b, Il1a, or Il4i1
in zVAD-treated cells.
This is surprising given our observation that zVAD treatment blocks IKK
phosphorylation as well as IL-12p40 and pro-IL-1β production to levels observed in
Ripk3-/-Casp8-/- macrophages in response to CpG stimulation. It is not likely that zVAD
incompletely inhibits caspase-8 catalytic activity as we can detect no activity in response
to LPS, CpG, or staurosporine in zVAD-treated cells (Fig 3.1A). However, the caspase-8specific inhibitor IETD completely abrogates transcription of Il12b in response to both LPS
and CpG. Therefore, it is possible that there is some latent caspase-8 activity in
zVAD-treated cells that we cannot detect with our caspase-8-activity assay.
We also observed a partial block of c-Rel translocation in macrophages treated with
zVAD, and we interpret these data to mean that both caspase-8 scaffolding and enzymatic
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activity contribute to c-Rel translocation in response to LPS and CpG stimulation. These
data are consistent with the observed dual contributions of caspase-8 enzymatic activity
and scaffolding in gene transcription in response to LPS; however, it appears that this
partial block is sufficient to inhibit cytokine secretion to levels observed in Ripk3-/-Casp8-/macrophages. It is clear from these data that cytokine secretion does not reflect gene
transcription with enough fidelity for cytokine secretion to serve as a proxy for the levels
of mRNA induced in response to TLR stimuli. These data also suggest that there is a
threshold of transcript required in macrophages to mediate wild-type levels of cytokine
secretion. If this is indeed the case, then caspase-8 enzymatic activity is critical for the
purposes of cytokine secretion in macrophages, and its inhibition is sufficient to mimic
complete ablation of caspase-8.
Our data demonstrated that immortalized Ripk3-/-Casp8-/- macrophages transduced
with catalytically inactive caspase-8 have intermediate levels of cytokine secretion,
suggesting some contribution of caspase-8 scaffolding in this context. One caveat to these
data are that immortalized macrophages secrete fewer cytokines than primary cells, and
Ripk3-/-Casp8-/- macrophages transduced with wild-type caspase-8 have no detectable
IL-12p40 as measured by ELISA or flow-cytometry (data not shown). TNF is the only
cytokine that is measurable in these cultures; therefore, it is possible that if we were able
to generate primary cells expressing catalytically inactive caspase-8 we would observe a
requirement for its activity in IL-12 secretion, as we see in chemically inhibited primary
cells. However, this is entirely speculative given the technical limitations of this
experiment.
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We also reported a surprising role for RIPK3 in the context of a mutant form of
caspase-8 that is unable to mediate apoptosis. Ripk3-/-Casp8DA/DA macrophages had
intermediate levels of IKK phosphorylation and gene expression when compared to Ripk3-/and Ripk3-/-Casp8-/- macrophages (Fig 3.6C and Fig 3.6E), whereas Casp8DA/DA
macrophages phenocopied B6 macrophages stimulated with LPS (Fig 3.6A and Fig 3.6B).
This suggests that RIPK3 promotes stabilization of the catalytic site of Casp8DA/DA. This is
surprising given that caspase-8 and RIPK3 are reported to exist in distinct complexes [105,
108]. However, RIPK3 is reported to be a substrate of caspase-8 [111] and other groups
have implicated RIPK3 indirectly in apoptosis and [126] inflammasome activation [127].
Therefore, it is possible that RIPK1, RIPK3, cFLIP, FADD, TRADD, and caspase-8
interact more dynamically than is assumed in the Complex I, Complex II and necrosome
transition model of different forms of cell death. It is likely that a combination of signals
bias cells towards preferential interactions between these proteins, RIPK3/RIPK1 in the
context of programed necrosis, RIPK1/caspase-8 in apoptosis, and RIPK1/cFLIP/caspase8 under pro-survival conditions. Our data suggest that in response to TLR stimulation
RIPK3 promotes the inflammatory gene regulatory function of Casp8DA/DA, perhaps via
stabilization of its catalytic site.
To our knowledge these studies represent the first report of caspase-8 activity in
response to TLR9 activation. We also demonstrate a role for caspase-8 enzymatic activity
in IKK phosphorylation, c-Rel translocation, and Il12b and Il1b transcription in response
to both LPS and CpG (Fig 3.7). These data support a model in which caspase-8 enzymatic
activity is a key component of inflammatory gene expression in response to multiple TLRs.
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3.5 Figures

Fig 3.1 TLR stimulation promotes caspase-8 catalytic activity.
(A) IETDase activity (arbitrary fluorescence units) in Ripk3-/- BMDMs 3.5hrs post
staurosporine treatment or 30min post LPS or CpG stimulation in the presence or absence
of zVAD, as indicated.
(B) CYLD cleavage in Ripk3-/- BMDMs 4hrs post LPS stimulation was measured by
immunoblotting cell lysates for CYLD in cells pre-treated with zVAD, IETD or vehicle
control as indicated 1hr prior to stimulation.
Error bars indicate ± SEM of triplicates. Student’s two-tailed unpaired t-test (** p<0.01,
**** p<0.0001). (A) is from an individual experiment and (B) is representative of three
independent experiments.
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Fig 3.2 Caspase-8 enzymatic activity regulates activation of the IKK complex.
(A) Fold-change in mRNA expression of indicated genes in Ripk3-/- and Ripk3-/-Casp8-/BMDMs pre-treated with zVAD or vehicle control for 1hr followed by treatment with LPS
or CpG for 2hrs.
(B) Levels of secreted IL-12p40, measured by ELISA, and frequency of intracellular
pro-IL-1β expression, measured by flow cytometry, by Ripk3-/- and Ripk3-/-Casp8-/BMDMs pre-treated with zVAD or vehicle control for 1hr followed by LPS or CpG
treatment for 5hrs.
(C) Immunoblots of phospho-IKKα/β and total IKKβ in Ripk3-/- BMDMs pre-treated with
zVAD or vehicle control for 1hr and stimulated with LPS or CpG for the indicated times.
Error bars indicate ± SEM of triplicates. Student’s two-tailed unpaired t-test (n.s. not
significant, * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001). All data representative of
three independent experiments.
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Fig 3.3 Caspase-8 enzymatic activity mediates Il12b expression in response to TLR
activation.
(A) Secreted IL-12p40 assayed by ELISA in supernatants of Ripk3-/- BMDMs pre-treated
with IETD or vehicle control (DMSO) for 1hr followed by 5hr stimulation with LPS or
CpG.
(B) Fold change in Il12b expression in Ripk3-/- and Ripk3-/-Casp8-/- BMDMs pre-treated
with IETD or vehicle control for 1hr prior to 2hrsof LPS or CpG treatment.
Error bars indicate ± SEM of triplicates. Student’s two-tailed unpaired t-test (** p<0.01,
*** p<0.001, **** p<0.0001). Data are representative of two independent experiments.
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Fig 3.4 Caspase-8 enzymatic activity contributes to c-Rel nuclear translocation in response
to TLR signaling.
(A) Representative confocal microscopy images of Ripk3-/- and Ripk3-/-Casp8-/- BMDMs
pre-treated with zVAD or vehicle control for 1hr followed by LPS or CpG stimulation as
indicated for 2hrs; c-Rel, actin and DAPI pseudo-colored in green, white and blue
respectively.

73

Fig 3.4 Continued: (B) Quantification of the mean fluorescence intensity of
nuclear:cytoplasmic c-Rel in Ripk3-/- and Ripk3-/-Casp8-/- BMDMs pre-treated with zVAD
or vehicle control for 1hr prior to LPS or CpG treatment for 2hrs.
Box plots represent 60-150 individual cells per condition. Student’s two-tailed unpaired
t-test (n.s. not significant, * p<0.05, ** p<0.01, **** p<0.0001). Box plots illustrate the
median, upper and lower quartiles, and upper and lower extremes of the data. All data
representative of at least three independent experiments.
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Fig 3.5 Caspase-8 enzymatic activity and scaffolding promote inflammatory cytokine
secretion.
(A) Depiction of the caspase-8 constructs transduced into Ripk3-/-Casp8-/- iBMDMs.
(B-C) ELISA measurement of secreted TNF in Ripk3-/-Casp8-/- iBMDMs transduced with
WT caspase 8 (Casp8WT), catalytically inactive caspase 8 (Casp8D3A), or an empty vector
and stimulated with LPS or CpG as indicated for 12hrs.
Error bars indicate ± SEM of triplicates. Student’s two-tailed unpaired t-test (** p<0.01,
*** p<0.001, **** p<0.0001). Data are representative of two independent experiments.
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Fig 3.6 Non-cleavable caspase-8 promotes inflammatory gene expression and IKK
phosphorylation in response to TLR stimulation.
(A) Fold-change in Il12b expression in B6 and Casp8DA/DA BMDMs stimulated with LPS
for 2hrs.
(B) Immunoblots of phospho-IKKα/β and total IKKβ in B6 and Casp8DA/DA BMDMs
stimulated with LPS for the indicated times.
(C) Fold-change in Il12b expression in Ripk3-/- , Ripk3-/-Casp8-/- , and Ripk3-/-Casp8DA/DA
BMDMs stimulated with LPS for 2hrs.
(D) Secreted IL-12p40 assayed by ELISA in supernatants of B6, Casp8DA/DA, Ripk3-/- ,
Ripk3-/-Casp8-/- , and Ripk3-/-Casp8DA/DA BMDMs stimulated with LPS for 6hrs.
(E) Immunoblots of phospho-IKKα/β and total IKKβ from Ripk3-/-, Ripk3-/-Casp8-/-, and
Ripk3-/-Casp8DA/DA BMDMs after LPS stimulation for indicated times.
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Fig 3.6 Continued: Error bars indicate ± SEM of triplicates. Student’s two-tailed unpaired
t-test (n.s. not significant, ** p<0.01, *** p<0.001, **** p<0.0001). Data are representative
of three independent experiments.
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Fig 3.7 Graphical abstract and future directions: Caspase-8 enzymatic activity and
scaffolding mediate inflammatory gene expression.
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CHAPTER 4: Selective ablation of caspase-8 apoptotic activity protects
thymocytes from Fas-mediated cell death and leads to the accumulation
of myeloid cells.
4.1 Abstract
Two critical functions of caspase-8-mediated apoptosis are the clearance of
autoreactive cells as well as pathogen-infected cells. Caspase-8-mediated apoptosis is
induced upon activation of tumor necrosis factor receptor superfamily members; this
family includes Fas/CD95 and TNFR1/2. Upon activation of these receptors by their
cognate ligands FADD is recruited to the death domain of the cytoplasmic portion of these
transmembrane proteins, and FADD in turn recruits caspase-8 via homotypic interactions
between their death effector domains. Upon recruitment caspase-8 monomers undergo
auto-processing through cleavage of the linker region between the p10 and p20 subunits of
each monomer. This auto-processing stabilizes two catalytic sites in the caspase-8
homodimer which mediate the cleavage of the apoptotic substrate BID (BH3-interacting
domain death agonist). Caspase-8 also negatively regulates another form of cell death:
programmed necrosis. In the absence of caspase-8 programmed necrosis is de-repressed
mediating embryonic lethality. Dual ablation of caspase-8 and the proteins that mediate
programmed necrosis—MLKL and RIPK3—rescues these mice from embryonic lethality.
Ripk3-/-Casp8-/- mice display a lymphoproliferative disease that is characterized by
splenomegaly, lymphadenopathy, and the accumulation of CD3+B220+ cells that begins
6-weeks postnatally. These characteristics are attributed to both a defect in programmed
necrosis and apoptosis, which prevents homeostatic turnover of circulating lymphocytes in
these mice. We sought to determine if specific ablation of caspase-8 apoptotic activity
recapitulated the observations made in Ripk3-/-Casp8-/- mice. We generated mice with a
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non-cleavable linker sequence between the p10 and p20 subunit of the caspase-8 monomer
referred to as Casp8DA/DA mice, and crossed these mice to RIPK3-deficient mice to generate
Ripk3-/-Casp8DA/DA mice. We were surprised to find that these mice display a unique
lymphoproliferative disease, distinct from Ripk3-/-Casp8-/- mice, that is characterized by
the accumulation of innate immune cell populations. These data suggest that caspsase-8
apoptotic activity is dispensable for lymphocyte homeostasis, but required for maintenance
of normal myeloid cell numbers.

80

4.2 Introduction
Caspase-8 plays a critical role in host survival through the clearance of autoreactive
cells [181], tumorigenic cells [182], and infected cells [183]. It is thought that caspase-8
mediates these functions through caspase-8-dependent apoptosis activated in response to a
variety of cell death stimuli. Broadly, death signals such as FasL (Tumor necrosis factor
ligand superfamily member 6) or TNF (Tumor necrosis factor) bind to their cognate
receptors which belong to the tumor necrosis receptor superfamily. Upon receptor
activation the adaptor proteins FADD [168] (Fas-associated death domain protein) and
TRADD [84] (Tumor necrosis factor receptor type 1-associated death domain protein) are
recruited to the cytoplasmic domain of the transmembrane death receptor via their death
domains (DD). TRADD and FADD indirectly or directly mediate recruitment of caspase-8
[184] forming the death inducing signaling complex (DISC). Under death inducing
conditions caspase-8 monomers oligomerize [85], and undergo auto-processing which
stabilizes their apoptotic activity [79]. Patients with non-functional caspase-8 display a
lymphoproliferative disease [157] that is similar to disease displayed in patients with
mutations in the death receptor Fas [165] as well as its cognate ligand FasL [185]. Studies
elucidating the role caspase-8 in lymphocyte homeostasis in vivo were historically difficult
as single ablation of caspase-8 results in embryonic lethality. However, in 2011 two groups
demonstrated that dual ablation of caspase-8 and RIPK3 (Receptor-interacting
serine/threonine-protein kinase 3), which mediates another cell death pathway known as
program necrosis, resulted in viable progeny [104, 105]. These groups implicated
caspase-8 in the negative regulation of programmed necrosis during development as well
as during cellular activation [104, 105].
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Mice in which both RIPK3 and caspase-8 are ablated display lymphoproliferative
disease that resembles the phenotype of mice with Fas or FasL mutations: lpr and gld mice
respectively [105, 186]. Lymphoaccumulation in Ripk3-/-Casp8-/- mice begins 6 weeks
postnatally, and is characterized by splenomegaly, lymphadenopathy, and accumulation of
CD3+B220+CD8-CD4-

cells

[105].

RIPK3-deficient

mice

do

not

display

lymphoproliferative disease, which suggests that caspase-8-dependent apoptosis promotes
clearance of circulating lymphocytes as mice age. These data were not entirely surprising
given that Fas-mediated cell death is important for regulating autoreactive T cells [187] as
well as total numbers of naïve T cells in the periphery [188].
In addition to its role in cell death caspase-8 has been implicated in the regulation
of inflammatory gene expression. However, in vivo these studies were performed using
Ripk3-/-Casp8-/- mice which display a defect in caspase-8-dependent apoptosis as well as
gene expression [75, 77, 110] during infection. In an effort to separate the gene-regulatory
function of caspase-8 from its apoptotic function we generated mice in which the apoptotic
confirmation of caspase-8 is rendered unstable. The apoptotic confirmation of caspase-8 is
stabilized in part through auto-processing of the linker sequence between its p10 and p20
subunits [79, 80]. Therefore, we generated a mouse in which this sequence is mutated
which we will refer to as Casp8DA/DA [75]. We have previously demonstrated that cells
derived from these mice are able to produce inflammatory cytokines in response to the
TLR4 agonist LPS, but do not undergo apoptosis when infected with the gram-negative
bacterial pathogen Yersinia pseudotuberculosis—a potent activator of caspase-8-mediated
apoptosis [75]. To further elucidate the role of caspase-8-mediated gene regulation in host
defense in vivo we generated Ripk3-/-Casp8DA/DA mice in which caspase-8-dependent
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apoptosis and RIPK3-dependent programmed necrosis are ablated (Fig 4.1). In this chapter
we discuss both our preliminary characterizations of these mice, and our discovery that
caspase-8-dependent apoptosis may play a novel role in regulating myeloid cell
populations in naïve mice.
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4.3 Results
4.3.1 Ripk3-/-Casp8DA/DA mice display a lymphoproliferative disease that is divergent from
that of Ripk3-/-Casp8-/- mice.
Previous studies have identified a role for caspase-8 in preventing splenomegaly
and lymphadenopathy [104, 105], which has been attributed to caspase-8-mediated
apoptosis in response to Fas stimulation. These mice are completely protected from Fasmediated apoptosis leading to the accumulation of a CD3+B220+CD4-CD8- cell population
in the periphery [105]. In an effort to isolate the role of caspase-8-mediated inflammatory
cytokine expression from its role in apoptosis we generated a mouse in which
caspase-8-dependent apoptosis and RIPK3-mediated programed necrosis are ablated, but
the cytokine regulatory function of caspase-8 is preserved (Fig 4.1). These mice will be
referred to as Ripk3-/-Casp8DA/DA. We anticipated that these mice would display the same
lymphoproliferative disease observed in Ripk3-/-Casp8-/- mice, and Ripk3-/-Casp8DA/DA mice
do exhibit splenomegaly similar to Ripk3-/-Casp8-/- mice (Fig 4.2A and Fig 4.2B).
However, unlike mice in which caspase-8 is ablated there is no observable
lymphadenopathy in Ripk3-/-Casp8DA/DA mice (Fig 4.2C). Moreover, in Ripk3-/-Casp8DA/DA
mice we could not detect the CD3+B220+CD4-CD8- T cell population that characterizes
Ripk3-/-Casp8-/- mice (Fig 4.3A and Fig 4.3B). These data were surprising given that the
accumulation of this cell population is what mediates splenomegaly and lymphadenopathy
in Ripk3-/-Casp8-/- mice; therefore, we then took a histological approach to asses immune
cell populations in the spleens of Ripk3-/-Casp8DA/DA mice.
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4.3.2 Ablation of capsase-8 apoptotic activity mediates splenomegaly that is characterized
by both myeloid and lymphocyte infiltration.
Histological analysis of the spleens of Ripk3-/-Casp8DA/DA mice revealed large
disruptions in the overall splenic architecture (Fig 4.4) characterized by atypical
lymphocyte expansion in the white pulp, lymphoid atrophy, and severe extramedullary
erythropoiesis. This disruption in splenic architecture is not present in Ripk3-/-Casp8-/mice. Staining for immune populations (CD3+ T cell, CD45+ total immune cells, and
F4/80+ monocytes/macrophage) also showed a divergent cellular infiltrate phenotype in
the spleens of Ripk3-/-Casp8DA/DA mice when compared to those of Ripk3-/-Casp8-/- mice.
Ripk3-/-Casp8DA/DA mice had CD3+ cells that expanded into the while pulp compressing the
remaining follicles, whereas follicular architecture was persevered in the Ripk3-/-Casp8-/mice and lymphocyte proliferation was restricted to the marginal zone (Fig 4.4).
Surprisingly, Ripk3-/-Casp8DA/DA mice had robust infiltration of macrophages and
monocytes in both the white and red pulp of the spleen (Fig 4.4). These data implicated
myeloid cells as well as CD3+ lymphocytes in the observed splenomegaly in
Ripk3-/-Casp8DA/DA mice. We then sought to characterize differences in circulating cell
populations as well as those in secondary lymphoid structures that did not display
differences in total organ weight or cellularity.

4.3.3 Ablation of the apoptotic activity of caspase-8 correlates with innate immune
population expansion in secondary lymphoid organs.
Previous groups have described a population CD3+B220+ cells that mediates the
lymphadenopathy in Ripk3-/-Casp8-/- mice [104, 105]. However, Ripk3-/-Casp8DA/DA mice
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do not have this population suggesting that there is a clear divergence between the
phenotypes of Ripk3-/-Casp8DA/DA and Ripk3-/-Casp8-/- mice. Therefore, we characterized
Ripk3-/-Casp8DA/DA mice in comparison with Ripk3-/- controls, and observed that
Ripk3-/-Casp8DA/DA mice had no observable lymphadenopathy and even displayed a trend
to overall lower cell counts in their mesenteric lymph nodes (mLNs) (Fig 4.2C and Fig
4.5A). In the mLNs we observed a decrease in overall CD8+ T cells with a trend towards
lower CD4+ T cell numbers (Fig 4.5B and Fig 4.6A). In the blood there was also a trend
towards an increase in CD8-CD4-CD3+ cells which is concordant with our histological
observations in the spleen (Fig 4.5C). There was a large increase in total numbers of
monocytes/macrophages and neutrophils in the mLNs of Ripk3-/-Casp8DA/DA mice when
compared to Ripk3-/- mice (Fig 4.5D, Fig 4.5E and Fig 4.6B). These data suggested that
caspase-8 apoptotic activity is required for maintenance of homeostatic levels of myeloid
populations in secondary lymphoid organs. However, it is unclear why the expansion of
myeloid cells was not observed in Ripk3-/-Casp8-/- mice [105]. The other group describing
these mice observed no differences in frequencies of neutrophils and monocytes in the
lymph node that they analyzed [104]; however, they do not state which lymph node they
isolated, and they did not calculate total cell numbers. Data that we will discuss in Chapter
6 suggest that Ripk3-/-Casp8-/- mice do not have increased numbers of myeloid cells in the
context of bacterial infection. The observed decrease in CD8+ T cells in the mLNs of
Ripk3-/-Casp8DA/DA mice prompted us to investigate if these mice had any defects in thymic
development.
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4.3.4 Caspase-8 apoptosis is dispensable for T cell development in the thymus.
The observed accumulation of CD3+CD4-CD8- cells in the spleen as well as the
decrease in overall CD8+ T cell numbers suggested a defect in the transition of DN to DP
cells in the thymus. However, we were unable to observe any differences between
Ripk3-/-Casp8DA/DA and Ripk3-/- mice in progression from DN to DP nor in positive
selection of CD4+ and CD8+ single positive cells expressing TCRβ (Fig 4.7A). Moreover
we could not observe any difference in thymic weights or cellularity between
Ripk3-/-Casp8DA/DA and Ripk3-/- mice (Fig 4.7B and Fig 4.7C). We then measured the
sensitivity of DP and single positive thymocytes to Fas stimulation with the expectation
that they should be protected due to the ablation of caspase-8 apoptotic activity. However,
we were surprised to find that only DP and CD4+ thymocytes from Ripk3-/-Casp8DA/DA mice
were protected from Fas-dependent apoptosis (Fig 4.7E and Fig 4.7F). CD8+ cells were
not protected from Fas-dependent apoptosis, which could explain why we observed less
overall CD8+ cells in the mLNs of Ripk3-/-Casp8DA/DA mice (Fig 4.5B and Fig 4.7D). These
data were unexpected as complete ablation of caspase-8 protects thymocytes from
Fas-dependent apoptosis, but the group that reported this phenotype only performed this
analysis on bulk thymocytes [105] of which DP cells are the majority of the total
population. We found that these cells have no defect in caspase-9-mediated apoptosis—
cell death induced by the caspase-8/9 agonist staurosporine was more robust in
Ripk3-/-Casp8DA/DA single positive thymocytes (Fig 4.7D, Fig 4.7E and Fig 4.7F). Overall
these data suggest that the non-apoptotic conformation of caspase-8 is sufficient to
mediated Fas-dependent cell death in CD8+ thymocytes, but not in CD4+ or DP cells.
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4.4 Discussion
Given the recent evidence that caspase-8 mediates cell death as well as
inflammatory gene expression [75, 77, 110] we sought to specifically evaluate the
contribution of caspase-8-dependent cytokine production to host defense in vivo.
Caspase-8 apoptotic activity is stabilized through the auto-processing of a linker sequence
between the p10 and p20 subunit of each caspase-8 monomer [79, 80]. We generated a
mouse in which the residue that is required for this cleavage is mutated (D387A) [80]
preventing auto-processing, and destabilizing the apoptotic conformation of caspase-8. We
have previously demonstrated that macrophages derived from these mice are protected
from caspase-8-dependent apoptosis, but produce inflammatory cytokines when stimulated
with LPS [75]. These mice were further crossed onto Ripk3-/- mice to generate a line that
was deficient for caspase-8-mediated apoptosis and RIPK3-dependent programmed
necrosis, but sufficient for the cytokine regulatory function of caspase-8. These mice were
generated in an effort to directly compare mice in which caspase-8 is completely ablated—
which must be done on a RIPK3-deficient background—to mice expressing the
conformation of caspase-8 that mediates inflammatory cytokine expression. We performed
initial characterizations of the progeny of these crosses with the expectation that their
phenotype would largely recapitulate that of Ripk3-/-Casp8-/- mice. While there were
superficial similarities between these mice, such as splenomegaly, there were pronounced
differences in immune cell populations between each line.
Ripk3-/-Casp8DA/DA display splenomegaly characterized by a disruption in splenic
architecture (Fig 4.4). The reasons for this disruption are not clear as caspase-8-dependent
apoptosis is known to play a role in overall embryonic development, but to our knowledge
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no one has implicated this function in the development of germinal centers in the spleen.
RIPK3 is dispensable for development of these structures as Ripk3-/- mice have no
histological defects in their splenic architecture (Fig 4.4). Furthermore, a defect in
apoptosis is not sufficient to explain the aberrant splenic architecture in Ripk3-/-Casp8DA/DA
mice as Ripk3-/-Casp8-/- mice do not have this phenotype. It is possible that this disruption
is not due to a defect in development per se, but rather due to myeloid and CD3+
lymphocyte infiltrate into the while pulp of the spleens isolated from Ripk3-/-Casp8DA/DA
mice; however, this explanation is entirely speculative.
The observed accumulation of myeloid cells in the mLNs of Ripk3-/-Casp8DA/DA
mice was surprising given that Ripk3-/-Casp8-/- mice are not reported to display this type of
cellular accumulation. One potential explanation is that because caspase-8 promotes the
secretion of chemokines (Chapter 2) there is sufficient recruitment of myeloid cells from
the bone marrow, but because apoptosis is impaired there is a defect in clearance under
steady-state conditions. Neutrophils in particular have a very short circulating half-life
(5-6hrs) [189]; therefore, caspase-8 apoptotic activity might play a critical role in control
of neutrophil numbers. These data, while interesting, also require further mechanistic
investigation to define the role of caspase-8-mediated apoptosis in monocyte and
neutrophil turnover.
The most notable hallmark of the lymphoproliferative disease seen in
Ripk3-/-Casp8-/- mice is their accumulation of CD3+B220+CD4-CD8- lymphocytes—this
phenotype largely mimics observations in lpr and gld mice which have defects in the genes
encoding Fas and FasL respectively [105, 186]. Interestingly, we observed an accumulation
of CD3+ cells in the spleens of Ripk3-/-Casp8DA/DA mice as well as a trend towards
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accumulation in the blood, but these cells do not express B220+; suggesting they are an
alternative population of double negative T cells. We hypothesized that this accumulation
was due to a defect in thymic development leading to an increase in the circulation of
double negative cells in the periphery, but our characterizations of thymic cellularity,
thymic weight, and T cell development revealed no differences between Ripk3-/-Casp8DA/DA
and Ripk3-/- mice (Fig 4.7). More comprehensive analysis is required to determine what
lymphocyte population these cells belong to, and whether these cells mediate the
splenomegaly we observed in

Ripk3-/-Casp8DA/DA mice. More intriguingly, if this

population of CD3+CD4-CD8-B220- cells is limited by caspase-8-dependent apoptosis then
these data implicate caspase-8 in the regulation of a novel cell population under steadystate conditions.
Overall, these data demonstrate a specific role for caspase-8-mediated apoptosis in
maintenance of myeloid and CD3+ lymphocyte populations in naïve mice; however,
non-cleavable caspase-8 appears to be sufficient to prevent the accumulation of
CD3+B220+CD4-CD8- cells in the periphery. The expression of non-cleavable caspase-8 is
also sufficient to mediate Fas-dependent apoptosis in CD8+ thymocytes, but not in double
positive or CD4+ populations. In Chapter 3 we demonstrated that Ripk3-/-Casp8DA/DA and
Ripk3-/- macrophages secrete cytokines to the same magnitude when stimulated with the
TLR4 agonist LPS. We also observed that the cytokine regulatory function of caspase-8 is
partially dependent on its enzymatic activity, which suggests that non-cleavable caspase-8
is enzymatically active in this context. It is possible that in CD8+ cells the non-cleavable
conformation of caspase-8 is sufficient to mediate Fas-induced apoptosis, which would
reflect novel differences in caspase-8 enzymatic and structural requirements for the
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induction of cell death in naïve T cell populations. In Chapters 5 and 6 we explore the role
non-cleavable caspase-8 plays in host defense in vivo.
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4.5 Figures

Fig 4.1 RIPK3-null Casp8DA/DA mice are expected to be deficient in cell death pathways.
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Fig 4.2 Ablation of capsase-8 apoptotic activity mediates splenomegaly.
(A) Images of spleens isolated from 16-week-old female littermates (Ripk3-/-,
Ripk3-/-Casp8DA/DA, Ripk3-/-Casp8DA/+ and Ripk3-/-Casp8-/-).
(B)

Weights

of

spleens

isolated

from

16-week-old

female

mice

(Ripk3-/-,

Ripk3-/-Casp8DA/DA, Ripk3-/-Casp8DA/+, and Ripk3-/-Casp8-/-; n=3-7 per mouse).
(C) Weights of mLNs isolated from 16-week-old female mice (Ripk3-/-, Ripk3-/-Casp8DA/DA,
and Ripk3-/-Casp8-/-; n=3-4 except Ripk3-/-Casp8-/- n=1).
Student’s two-tailed unpaired t-test (n.s. not significant, *** p<0.001). Error bars indicate
± SEM. Pooled data from two different experiments.
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Fig 4.3 Non-cleavable capsase-8 protects mice from CD3+B220+ cell accumulation.
(A) Total numbers of live Lin-CD90+CD3+CD4-CD8-B220+ lymphocytes isolated from the
blood of 16 week old female littermates (Ripk3-/-, Ripk3-/-Casp8DA/DA, and Ripk3-/-Casp8-/; n=3 except Ripk3-/-Casp8-/- n=1).
(B) Total numbers of live Lin-CD3+CD4-CD8-B220+ lymphocytes isolated from the
spleens of 16-week-old female littermates (Ripk3-/-, Ripk3-/-Casp8DA/DA, and Ripk3-/-Casp8/-

; n=3 except Ripk3-/-Casp8-/- n=1).

Student’s two-tailed unpaired t-test (n.s. not significant). Error bars indicate ± SEM. All
data representative of two independent experiments. Lineage markers (CD19 and NK1.1)
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Fig 4.4 RIPK3-null Casp8DA/DA mice have disrupted splenic architecture and increased
immune cell infiltrate.
Representative images from H&E, CD3, CD45 and F4/80 stained spleen paraffin sections
prepared by the Children’s Hospital of Philadelphia Pathology Core. Analysis of sections
performed by Penn Veterinary Medicine Pathology Core (Ripk3-/- n=6, Ripk3-/-Casp8DA/DA
n=7, Ripk3-/-Casp8-/- n=2).
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Fig 4.5 RIPK3-null Casp8DA/DA mice have expanded populations of myeloid cells in
secondary lymphoid organs.
(A) Total cell numbers in mLNs isolated from Ripk3-/- and Ripk3-/-Casp8DA/DA mice (n=3).
(B) Live+CD3+ lymphocytes isolated from the mLNs of Ripk3-/- and Ripk3-/-Casp8DA/DA
mice (n=3).
(C)

Live+CD90+CD3+CD4-CD8-

lymphocytes

in

the

blood

of

Ripk3-/-

and

Ripk3-/-Casp8DA/DA mice (n=3).
(D) Live+CD3-CD19-CD45+F4/80+ cells isolated from the mLNs of Ripk3-/- and
Ripk3-/-Casp8DA/DA mice (n=3).
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Fig 4.5 continued: (D) Live+CD3-CD19-CD45+Ly6G+Ly6C+ cells isolated from the mLNs
of Ripk3-/- and Ripk3-/-Casp8DA/DA mice (n=3).
Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05, ** p<0.01). Error bars
indicate ± SEM. All data representative of two independent experiments.
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Fig 4.6 Representative gating strategy for the characterization of both innate and adaptive
immune populations in RIPK3-null Casp8DA/DA mice.
(A). Flow contour plot showing gating strategy for classification of CD4+, CD8+ and DN
T cells isolated from the mLN of a Ripk3-/- mouse.
(B). Flow contour plot showing gating strategy for classification of innate immune cell
populations isolated from the mLN of a Ripk3-/- mouse.
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Fig 4.7 RIPK3-null Casp8DA/DA mice have normal T cell development and are partially
protected from Fas-dependent apoptosis.
(A) Total numbers of DN, DP and single positive thymocytes isolated from Ripk3-/- and
Ripk3-/-Casp8DA/DA mice (n=3-4). Cells gated on live, singlets that were lineage negative.
Lineage markers (CD11b, CD11c, CD19, CD49, and Gr-1).
(B). Total weights of thymi isolated from Ripk3-/- and Ripk3-/-Casp8DA/DA mice (n=3-4).
(C). Total cell counts of thymi isolated from Ripk3-/- and Ripk3-/-Casp8DA/DA mice (n=3-4).
(D-E). Frequency of Annexin V+7AAD+ CD8+, CD4+ and DP thymocytes isolated from
Ripk3-/- and Ripk3-/-Casp8DA/DA and stimulated with the indicated concentrations of FasL
(with 25μg/mL cycloheximide) for 24hrs or 10μM staurosporine for 8hrs. (n=3-4
mice/group).
Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05, ** p<0.01,
*** p<0.001). Error bars indicate ± SEM. All data representative of two independent
experiments.
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CHAPTER 5: Caspase-8 promotes host survival during acute
Toxoplasma gondii infection.
5.1 Abstract
Caspase-8 has been recently implicated in the regulation of inflammatory gene
expression. Caspase-8-dependent cytokine secretion has been shown to mediate host
defense in response to gram-negative bacterial pathogens in vivo; however, it is unclear if
this function is required in other contexts. Il12b expression as well as the secretion of
IL-12p40 are significantly impaired in macrophages lacking caspase-8. IL-12p40 serves as
a subunit of both IL-23 and IL-12p70, two cytokines known to be important for host
survival during infection with a variety of pathogens. IL-12p70 is specifically critical for
the control of acute infection with the obligate, intracellular parasite Toxoplasma gondii.
T. gondii belongs to the Apicomplexa phylum which contains other pathogens such as
Plasmodium and Cryptosporidium parvum. T. gondii infects mammals through food or
water contaminated with cysts excreted in cat feces leading to a significant amount of
foodborne illness in the United States annually. C57BL/6 mice survive infection with the
attenuated strain of T. gondii (Prunigard), and this survival is dependent on the secretion
of IL-12p70 by dendritic cells. We show that caspase-8-deficient mice have an acute
survival defect that largely recapitulates the observed phenotype in IL-12p40-deficient
mice. Moreover, this defect is characterized by lower levels of IL-12p40 production by
caspase-8-deficient dendritic cells, and impaired monocyte recruitment into the peritoneum
of infected animals. Caspase-8-deficient animals can be rescued through exogenous
injection of IL-12p70, leading to parasite clearance, and recruitment of inflammatory
monocytes. To our knowledge these are the first studies implicating caspase-8-mediated
cytokine secretion in host survival against a eukaryotic pathogen.
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5.2 Introduction
Caspase-8 plays a cell-intrinsic role in inflammatory cytokine secretion in vitro and
in vivo during infection with the gram-negative bacterial pathogen Yersinia
pseudotuberculosis [75]. Others have demonstrated a role for caspase-8 in cytokine
secretion during infection with another gram-negative enteric pathogen Citrobacter
rodentium [110]. However, to our knowledge no one has tested the role for caspase-8 in
survival during infection with a eukaryotic pathogen. Toxoplasma gondii is endemic to the
United States, and causes a significant percentage of domestic foodborne illness cases
annually [136]. Most carriers are asymptomatic, but pregnant women and
immunocompromised individuals are at significant risk for life-threatening complications
associated with toxoplasmosis [135]. C57BL/6 mice largely survive acute infection with
the attenuated Prunigard strain of T.gondii, and this survival is dependent on the production
of IL-12 [137], and Il12b-/- mice rapidly succumb to acute T. gondii infection [138].
The primary source of IL-12 during T. gondii infection is thought to be from
uninfected inflammatory monocytes and conventional dendritic cells that detect T. gondii
antigen [139]. Detection of T. gondii by dendritic cells is mediated in part by TLR11 and
TLR12 upon recognition of profilin [190]. Secreted IL-12 then induces IFNγ production
by NK cells in addition to cytotoxic CD8 and CD4 T cells; IFNγ promotes killing of
infected cells through cell-extrinsic and cell-intrinsic mechanisms [140, 142, 191-193].
Interestingly, T. gondii actively suppresses apoptosis; therefore, the primary mechanism of
clearance is T-cell-mediated killing or induction of intracellular reactive oxygen species in
infected cells [142, 144, 145, 194]. Cytokine secretion is particularly important in this
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context as it is required for the recruitment of T cells as well as paracrine signaling from
bystander cells to infected cells.
We have shown that caspase-8-deficient macrophages have a defect in the
expression of Il12b and secretion of IL-12p40 (Chapter 2). Moreover, in vivo there is a
cell-intrinsic defect in IL-12p40 production in caspase-8-deficient monocytes and
neutrophils during gram-negative bacterial infection [75]. These data provoked the
hypothesis that caspase-8 may play a role in host defense during T. gondii infection via its
cytokine regulatory function, specifically through the expression of IL-12. Although
caspase-8 mediates both cell death and inflammatory cytokine expression, host defense
during T. gondii infection is largely dependent on cytokine production by responding innate
immune cells. Therefore, we hypothesized that caspase-8-mediated cell death would be
dispensable for host survival during T. gondii infection.
We utilized two models to interrogate the role of caspase-8 in host defense against
T. gondii: one in which caspase-8 was completely ablated, and one in which caspase-8apoptotic activity was disrupted while preserving its cytokine regulatory function. We
found a requirement for caspase-8 in host survival during T. gondii infection that was
indistinguishable from the requirement for IL-12. Moreover, caspase-8-deficient animals
had a defect in IL-12p40 production by dendritic cells, and survival of these mice could be
completely rescued through the exogenous injection of IL-12p70. To our knowledge these
data are the first to demonstrate a role for caspase-8 in host survival during infection with
an intracellular, eukaryotic pathogen via the cytokine regulatory function of caspase-8.
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5.3 Results
5.3.1 Caspase-8-deficient animals are acutely susceptible to T. gondii infection.
IL-12-deficient animals have a pronounced survival defect during intraperitoneal
infection with a low dose (10,000 tachyzoites) of an attenuated strain of T. gondii
(Prunigard, Pru). We observed a role for caspase-8 in the induction of Il12b in
macrophages, but Il12b expression and IL-12p40 secretion are not completely abrogated
in this context. Therefore, we were surprised to find that Ripk3-/-Casp8-/- mice were just as
susceptible to T. gondii infection as Il12b-/- mice (Fig 5.1A). Ripk3-/-Casp8-/- mice had
parasite burdens that were statistically indistinguishable from Il12b-/- mice suggesting that
caspase-8 mediates host survival through control of parasite replication (Fig 5.1C).
Cytospins of peritoneal exudate cells (PECs) also show that Il12b-/- and Ripk3-/-Casp8-/mice have similar numbers of parasites per cell (Fig 5.1B and Fig 5.1D). Dendritic cells
(DCs) in the PECs of infected Ripk3-/-Casp8-/- mice had impaired production of IL-12p40
(Fig 5.2A). Representative flow plots show the gating strategy for identifying LinCD64-CD11c+MHCII+ DCs as well as representative IL-12p40 staining in DCs from the
PECs of B6, Ripk3-/-, Ripk3-/-Casp8-/-, and Il12b-/- mice 5 days post infection (Fig 5.2B and
Fig 5.2C). As dendritic cells are the primary mediators of IL-12p40 production during T.
gondii infection these data suggest that impaired survival of caspase-8-deficient animals
was due to failure to induce sufficient IL-12p40. Interestingly, IL-12p40 production by
DCs in Ripk3-/-Casp8-/- mice was not completely abrogated, but this amount of cytokine
production appeared to be below the threshold required to mediate host survival.
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5.3.2 IL-12 rescues caspase-8-deficient animals during acute T. gondii infection.
We hypothesized that exogenous IL-12 would restore host survival in caspase-8deficient animals by compensating for the observed defect in IL-12 production by DCs. As
expected IL-12 injections rescued Il12b-/- mice, and were also sufficient to completely
rescue Ripk3-/-Casp8-/- mice (Fig 5.3A). Moreover, IL-12 treatment reduced parasite
burdens in Ripk3-/-Casp8-/- mice to levels observed in B6 and Ripk3-/- mice (Fig 5.3B and
Fig 5.3C). Another mechanism of parasite control is through infiltration of inflammatory
monocytes that promote parasite killing [195]. We observed a defect in recruitment of
inflammatory monocytes by total cell number as well as frequency into the peritoneum of
caspase-8-deficient animals (Fig 5.3D and Fig 5.3E). Interestingly, this impaired
recruitment was very similar to that observed in Il12b-/- mice, again suggesting that a
threshold of IL-12 production is required to mount an innate response to T. gondii infection.
We were also able to restore infiltration of inflammatory monocytes with the injection of
exogenous IL-12. While these data are correlative they suggest that caspase-8-dependent
IL-12 secretion mediates host defense during T. gondii infection.

5.3.3 IL-12 rescues c-Rel-deficient animals during acute T. gondii infection.
We have previously shown that in macrophages caspase-8 promotes Il12b
expression in part through the transcription factor c-Rel (Chapter 2). Previous groups have
shown that c-Rel-dependent IL-12 is important for the adaptive response in an oral model
of T. gondii [196]. However, to our knowledge no one has investigated the contribution of
c-Rel to intraperitoneal infection with T. gondii tachyzoites. We found that Rel-/- animals
succumbed with similar kinetics to Il12b-/- animals, and that these mice were completely
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rescued by exogenous IL-12 (Fig 5.4). We interpret these data to mean that c-Rel dependent
IL-12 may also be protective in the intraperitoneal infection model of T. gondii, implicating
caspase-8 in the c-Rel/IL-12 axis in this system.

5.3.4 Expression of non-cleavable caspase-8 reduced host mortality during acute T. gondii
infection.
Although there is no reported role for caspase-8-dependent apoptosis in host
defense during T. gondii infection—this pathway is repressed in T.gondii-infected cells—
it was formally possible that caspase-8-dependent apoptosis contributes to survival. To
specifically test the contribution of caspase-8-mediated inflammatory cytokine secretion
during T. gondii infection we utilized a mouse model in which caspase-dependent apoptosis
and RIPK3-mediated programmed necrosis are ablated while preserving caspase-8cytokine secretion (Ripk3-/-Casp8DA/DA). Ripk3-/-Casp8DA/DA mice had reduced mortality
during T. gondii infection; however, not to the same magnitude as Ripk3-/- mice (Fig 5.5A).
There was also considerable variance in the percentage of infected PECs isolated from
Ripk3-/-Casp8DA/DA mice 5 days post infection suggesting that some mice fail to control
replication while others are able to (Fig 5.5B). These data implicated caspase-8-apoptotic
activity in host defense; however, mice that are sufficient for RIPK3, but also express noncleavable caspase-8 have no detectible parasites in their PECs 5 days post infection
(Fig 5.5C). One possible explanation for this observation is that RIPK3 may be required
to help stabilize the non-cleavable conformation of caspase-8 in dendritic cells during in
vivo infection with T. gondii. This would be surprising given that we can find no role for
RIPK3 in protection against T. gondii: Ripk3-/- mice have identical parasite burdens when

106

compared to B6 mice (Fig 5.1C). However, these data are preliminary as the experiments
in panel B and C were only performed once. More experiments are required to determine
if there is a synergistic effect between RIPK3 and non-cleavable caspase-8 during T. gondii
infection.

5.3.5 Ablation of caspase-8 in hematopoietic cells results in increased parasite burdens and
a defect in monocyte infiltration.
The observed decrease in IL-12 secretion from caspase-8-deficient DCs suggested
that caspase-8-mediated cytokine production in the immune compartment was the primary
mechanism that promoted host survival during acute T. gondii infection. To test this
hypothesis we generated bone marrow chimeras in which B6 mice were sublethally
irradiated, and reconstituted with bone marrow from B6, Ripk3-/-, Ripk3-/-Casp8-/-, and
Il12b-/- mice. These mice had parasite burdens that were concordant with our observations
in mice lacking Ripk3-/-Casp8-/- or Il12b-/- in both the hematopoietic and non-hematopoietic
compartments, suggesting that control of parasite burdens is largely mediated by caspase-8
in immune cells (Fig 5.6A). B6 mice with caspase-8 deficiency in their hematopoietic
compartment also have impaired monocyte recruitment into their peritoneum 5 days post
infection, providing additional evidence that this infiltration is mediated by caspase-8
expression in immune cells (Fig 5.6B). These data demonstrate a role for caspase-8
expression in hematopoietic cells during acute T. gondii infection.
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5.4 Discussion
To our knowledge these data implicate the cytokine regulatory function of
caspase-8 in host defense during T. gondii infection for the first time (Fig 5.7). The defect
in IL-12 production by caspase-8-deficient DCs suggests a broad role for caspase-8 in
cytokine production in a variety of innate immune cell populations in vivo. The observed
contribution of c-Rel to host survival provokes the hypothesis that the TLR/caspase-8/cRel axis may promote cytokine secretion by DCs as well as macrophages (Fig 5.8). We
have not tested the in vitro requirement for caspase-8 in IL-12 production by DCs infected
with T. gondii or stimulated with the T. gondii antigen STAg (soluble tachyzoite antigen),
but it is possible that we would observe a defect in IL-12 production in this context as well.
These data also demonstrate the principle of thresholding in the immune response
to inflammatory mediators. It appears that there is a threshold of IL-12 required for mice
to mount an early innate response to T. gondii. Unlike Il12b-/- mice, caspase-8-deficient
animals have some IL-12 production, but this amount of IL-12 is not sufficient to promote
control of parasite replication or recruitment of inflammatory monocytes into the
peritoneum of infected animals. These data are similar to our observations in which
caspase-8 expression in immune cells is required for maximal production of cytokines
during infection with Yersinia pseudotuberculosis [75]. However, the role of caspase-8 in
IL-12 production during T. gondii infection remains correlative. Mice with cDC-specific
depletion [197] would enable us to generate mixed bone marrow chimeras with bone
marrow from mice lacking cDCs and bone marrow from mice lacking caspase-8. This will
allow us to directly test the cell-intrinsic role of caspase-8, in cDCs in vivo, during T. gondii
infection.
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Given the requirement for caspase-8 in protection against an obligate, intracellular,
eukaryotic pathogen it would be interesting to test its role in control of another member of
the Apicomplexa phylum: Cryptosporidium parvum. Recent advances have made it
possible to culture C. parvum in vitro and inoculate mice with a rodent-adapted strain of
the parasite [198]. Very little is known about C. parvum-mediated antagonism of the host
immune response or the mechanisms of host control; therefore, investigations into the
possible role for caspase-8 in this model may provide insight into host-pathogen
interactions during C. parvum infection in vivo.
In these studies we also demonstrated a role for caspase-8-dependent cytokine
production separate from caspase-8-dependent apoptosis during T. gondii infection.
However, on a RIPK3-null background expression of non-cleavable caspase-8 was not
sufficient to mediate survival of all infected animals. We also observed significant
variability in parasite burdens from PECs isolated from Ripk3-/-Casp8DA/DA mice 5 days
post infection. From experiments discussed in Chapter 4 we know that Ripk3-/-Casp8DA/DA
mice have a defect in total numbers of CD8 T cells in their secondary lymphoid organs.
CD8 T cells are critical for host defense against T. gondii, and can be recruited into the
peritoneum very rapidly post infection [191]. Therefore, it is possible that the intermediate
survival phenotype observed in Ripk3-/-Casp8DA/DA mice could be attributed to a defect in
cytotoxic CD8 T cell recruitment into the peritoneum after infection, and not due to
impaired caspase-8-dependent apoptosis. We did not measure IFNγ production by NK cells
or adaptive cell populations in any of the experiments we conducted, nor did we test the
effector functions of these populations. These outstanding questions provide opportunities
for future studies to determine if the observed defect in IL-12 production correlates with
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impaired IFNγ production or impaired effector responses during T. gondii infection of
caspase-8-deficient mice. Collectively, the data described here provide evidence for the
broad protective role played by caspase-8 in response to infection, and the specific
contribution of caspase-8-mediated cytokine expression to host defense during infection
with a eukaryotic pathogen.
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5.5 Figures

Fig 5.1 Caspase-8 promotes survival during acute T. gondii infection.
(A) Survival of B6, Il12b-/-, Ripk3-/-, and Ripk3-/-Casp8-/- mice (n=5-10) infected
intraperitoneally with T.gondii.
(B) Representative cytospins of infected cells in the PECs of T.gondii-infected B6, Il12b-/,
Ripk3-/-, and Ripk3-/-Casp8-/- mice 5 days post-infection.
(C) Quantification of infected cell frequency and (D) parasites per cell in the PECs of
T. gondii-infected B6, Il12-/-, Ripk3-/-, and Ripk3-/-Casp8-/- mice 5 days post-infection; each
data point represents a single mouse.
For all infections 10,000 Pru T. gondii parasites were injected i.p. (A) Mantel-cox test
(** p<0.01, *** p<0.001). (C) and (D) Student’s two-tailed unpaired t-test
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Fig 5.1 Continued: (n.s. not significant, ** p<0.01, **** p<0.0001). Error bars indicate
± SEM. Data representative of three independent experiments.
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Fig 5.2. Caspase-8 promotes IL-12 production by DCs during acute T. gondii infection.
(A)

Frequency

of

IL-12p40+

CD64-Lin-

cells

(Live+Singlets+CD19-CD3-B220-

NK1.1-CD64-) in the PECs of T. gondii-infected B6, Il12b-/-, Ripk3-/-, and Ripk3-/-Casp8-/mice 5 days post infection.
(B) Representative flow contour plots of the gating strategy for CD11c+MHCII+ DCs
(orange) and MHCII+LY6Chi inflammatory monocytes (green) in the PECs of a T.gondiiinfected B6 mouse 5 days post infection.
(C) Representative flow contour plots of CD11c+MHCII+IL-12p40+ cells from the PECs
of T.gondii-infected B6, Il12b-/-, Ripk3-/-, and Ripk3-/-Casp8-/- mice 5 days post infection.
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Fig 5.2 Continued: For all infections 10,000 Pru T. gondii parasites were injected i.p.
Student’s two-tailed unpaired t-test (* p<0.05, *** p<0.001). Error bars indicate ± SEM.
Panel (A) is composed to pooled data from three independent experiments.
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Fig 5.3. Exogenous IL-12 rescues caspase-8-deficient animals during acute T. gondii
infection.
(A) Survival of mice infected with T. gondii and injected i.p. with PBS or rmIL-12p70
(200ng/mouse) for 7 days post infection (n=3-6).
(B) Representative cytospins from PECs isolated 5 days post infection from T. gondiiinfected B6, Il12b-/-, Ripk3-/-, and Ripk3-/-Casp8-/- mice injected i.p. with PBS or rmIL12p70 for 5 days post infection.
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Fig 5.3 Continued: (C) Quantification of the frequency of infected cells in the PECs of
PBS or rmIL-12p70-injected T.gondii-infected B6, Il12b-/-, Ripk3-/-, and Ripk3-/-Casp8-/mice 5 days post infection, each data point represents a mouse.
(D) Number and (E) frequency of inflammatory monocytes (Live+Singlets+CD19-CD3B220-NK1.1- CD64+MHCII+LY6Chi cells) in the PECs of PBS or rmIL-12p70-injected T.
gondii-infected B6, Il12b-/-, Ripk3-/-, and Ripk3-/-Casp8-/- mice 5 days post infection.
Each data point represents one mouse.
For all infections 10,000 Pru T. gondii parasites were injected i.p. (A) Mantel-cox test
(* p<0.05). (B), (D), and (E) Student’s two-tailed unpaired t-test (n.s. not significant,
* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001). Error bars indicate ± SEM. Panels
representative of two independent experiments.
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Fig 5.4. Exogenous IL-12 rescues c-Rel-deficient animals during acute T. gondii infection.
Survival of Ripk3-/-Casp8-/- and Rel-/- mice following T. gondii infection and injected i.p.
with PBS or rmIL-12p70 (200ng/mouse) for 7 days post infection (n=7 per group).
Mantel-cox test (** p<0.01). For all infections 10,000 Pru T. gondii parasites were injected
i.p. Representative of two independent experiments.
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Fig 5.5. Non-cleavable caspase-8 promotes host survival during acute T. gondii infection.
(A) Survival of Ripk3-/- , Ripk3-/-Casp8-/- , and Ripk3-/-Casp8DA/DA mice infected with
T. gondii (n=7-18).
(B) Frequency of infected cells in the PECs of T.gondii-infected Ripk3-/- , Ripk3-/-Casp8-/- ,
and Ripk3-/-Casp8DA/DA mice 5 days post infection, each data point represents a mouse.
(C) Frequency of infected cells in the PECs of T.gondii-infected B6, Casp8DA/DA mice, and
Il12b-/- mice 5 days post infection, each data point represents a mouse.
For all infections 10,000 Pru T. gondii parasites were injected i.p. (A) Mantel-cox test
(** p<0.01, *** p<0.001). (B) and (C) Student’s two-tailed unpaired t-test (n.s. not
significant, * p<0.05). Error bars indicate ± SEM. Panel (A) represents 3 pooled
independent experiments. Panels (B) and (C) were performed once.
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Fig 5.6. Caspase-8 deficiency in hematopoietic cells leads to increased parasite burdens
and impaired monocyte infiltration during T. gondii infection.
(A) Frequency of infected cells in the PECs of T. gondii-infected B6.SJL mice irradiated
and reconstituted with B6, Il12b-/-, Ripk3-/-, and Ripk3-/-Casp8-/- bone marrow 5 days post
infection, each data point represents an individual mouse.
(B) Frequency of inflammatory monocytes (Live+Singlets+CD19-CD3-B220-NK1.1CD64+MHCII+LY6Chi cells) in the PECs of B6.SJL mice reconstituted with B6, Il12b-/-,
Ripk3-/-, and Ripk3-/-Casp8-/- bone marrow and infected with T. gondii 5 days post infection.
Each data point represents a mouse.
For all infections 10,000 Pru T. gondii parasites were injected i.p. Student’s two-tailed
unpaired t-test (n.s. not significant, ** p<0.01, *** p<0.001). Error bars indicate ± SEM.
Panels show two pooled experiments from a total of three independent experiments.
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Fig 5.7. Graphical abstract: Caspase-8 promotes secretion of IL-12 in response to T. gondii
infection.
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Fig 5.8. Future directions: Potential in vitro mechanism of caspase-8-dependent Il12b
expression in DCs during T. gondii infection.
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CHAPTER 6: Non-cleavable caspase-8 mediates host survival during
infection with the gram-negative bacterial pathogen Yersinia
pseudotuberculosis.
6.1 Abstract
Caspase-8 positively regulates cell-extrinsic apoptosis and constitutively represses
RIPK3-mediated programmed necrosis, functions critical to immune homeostasis and host
defense. In addition to its well-characterized role in cell death, caspase-8 regulates
inflammatory cytokine secretion in vitro and in vivo. Data from our lab as well as others
have implicated caspase-8 in the immune response during infection with the gram-negative
enteric pathogens Citrobacter rodentium and Yersinia pseudotuberculosis (Yp). During
oral infection Yp mice deficient in caspase-8 in hematopoietic cells have an acute survival
defect and a cell-intrinsic defect in cytokine production. However, the relative contribution
of caspase-8-mediated cell death and inflammatory gene expression during Yp infection
has yet to be elucidated. To begin to resolve this question we generated mice in which
caspase-8 apoptotic activity was ablated while preserving its cytokine regulatory function.
We further crossed these mice onto a RIPK3-deficient background to directly compare
mice without caspase-8 expression to those expressing non-cleavable caspase-8 (nonapoptotic caspase-8). Mice lacking caspase-8 in both their hematopoietic and
nonhematopoietic cell populations were acutely susceptible to oral infection with Yp.
Moreover, expression of non-cleavable caspase-8 was sufficient to rescue mice during
infection, and these mice had reduced bacterial burdens. However, we were surprised to
find that, contrary to what has been observed in mice specifically lacking caspase-8 in their
hematopoietic cells, mice lacking caspase-8 in all cell populations had no defect in cytokine
production. These data suggest that the mortality observed in caspase-8-deficient mice was
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not due to the inability to mount an inflammatory cytokine response or apoptotic response,
but an alternative function of caspase-8 that is mediated by its non-cleavable conformation.
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6.2 Introduction
Caspase-8 is a cysteine protease that mediates cell-extrinsic apoptosis in response
to activation of death receptors such as Fas and TNFR [102], a function that is critical for
clearance of autoreactive cell populations [181, 199], tumorigenic cells [182], and virally
infected cells [128, 183]. Caspase-8 also negatively regulates another form of cell death
known as programmed necrosis [104, 105] through the cleavage of the K63 deubiquitinase
CYLD to prevent the activation of RIPK1/RIPK3-dependent necrosis [133]. In addition to
its role in cell death, caspase-8 has a recently described function in inflammatory cytokine
expression [75, 100, 110]. Caspase-8 is required for the expression of inflammatory
mediators in response to fungal [147] and bacterial [77] pathogens in vitro as well as to
bacterial pathogens in vivo [75, 110]. We have also identified a role for caspase-8-mediated
cytokine expression in host defense against the eukaryotic, obligate, intracellular pathogen
Toxoplasma gondii (Chapter 5). However, the relative contributions of caspase-8mediated cell death and caspase-8-mediated cytokine secretion to survival during bacterial
infection has yet to be defined. In this chapter we address the contributions of both of these
pathways to survival during infection with the gram-negative bacterial pathogen Yersinia
pseudotuberculosis.
Yersinia pseudotuberculosis is closely related to two other pathogenic Yersinia
spp.: Yersinia enterocolitica and Yersinia pestis. Yersinia enterocolitica and Yersinia
pseudotuberculosis cause self-limiting gastroenteritis in humans [148, 149], whereas
Yersinia pestis, the causative agent of plague, has a case-fatality rate of 30-90% when left
untreated, and is still endemic to the United States [153]. In rodents Y. pseudotuberculosis
mimics the systemic bacterial dissemination and disease symptomology observed in
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humans infected with Yersinia pestis [152, 200]. Yersinia spp. are potent activators of
apoptosis in immune cells via the effector protein YopJ (Yersinia outer protein J) which
antagonizes gene transcription [154, 155, 178]. We have previously shown that strains of
Yersinia spp. with reduced YopJ injection are more virulent [174], and apoptosis limits Y.
pseudotuberculosis virulence in vivo [132]. There is also evidence that in vivo cytokine
production, particularly IL-12 and TNF, promote host survival to Yersinia infection [98,
201]. Therefore, it is possible that there are distinct contributions of caspase-8-mediated
cell death and caspase-8-mediated cytokine secretion to host survival during infection with
Y. pseudotuberculosis.
We have previously shown that mice lacking caspase-8 in hematopoietic cells are
acutely susceptible to oral infection with Y. pseudotuberculosis [114]. Moreover, these
mice have increased bacterial burdens, and a defect in cytokine production in caspase-8deficient monocytes and neutrophils [114]. To test the specific contribution of caspase-8mediated cytokine production to host survival during Y. pseudotuberculosis we generated
a mouse in which the linker sequence between the p10 and p20 subunit of caspase-8 is
mutated to prevent auto-processing and stabilization of the apoptotic conformation of the
protein [79, 80]. We have previously shown that macrophages generated from these mice
are resistant to Yersinia-induced apoptosis, but are able to produce cytokines in response
to TLR stimuli [75]. These mice were also crossed onto RIPK3-null mice to generate a
mouse in which both apoptosis and programed necrosis are ablated while preserving the
cytokine regulatory function of caspase-8. This approach allowed us to specifically
interrogate the role of caspase-8-mediated cytokine secretion to host defense during oral
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infection with Yersinia pseudotuberculosis. In this studies we describe an in vivo role for
caspase-8 that is independent of both its cell death and cytokine regulatory functions.
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6.3 Results
6.3.1. Non-cleavable caspase-8 promotes host survival during oral infection with Yersinia
pseudotuberculosis.
We have previously shown that mice lacking caspase-8 in their hematopoietic cells
succumb to oral infection with Yersinia pseudotuberculosis (Yp) within 6 days of infection
[114]. Surprisingly, mice in which caspase-8 was ablated in all cell populations were even
more susceptible to Yp infection. Mice began to die 3 days post infection, and all mice
succumbed within 4 days (Fig 6.1A). We observed a role for RIPK3 in survival beginning
9 days post infection, which had not previously been observed in mice with hematopoieticspecific ablation of RIPK3 (Fig 6.1A) [114]. These data potentially implicate RIPK3 in the
adaptive response to Yp infection which has not been previously reported. One of the seven
effector proteins expressed by Yp is YopJ, which is known to promote systemic
dissemination of Yersinia [200]; however, YopJ-mediated apoptosis is also important for
host survival during Yersinia infection in some contexts [202]. To address the contribution
of caspase-8-dependent apoptosis in vivo in mice lacking caspase-8 in both their
hematopoietic and non-hematopoietic cell populations we orally infected Ripk3-/-Casp8-/mice with ΔYopJ. We hypothesized that if caspase-8-dependent apoptosis played a role in
host survival, mice deficient in caspase-8 would have increased survival during ΔYopJ
infection, which has been observed in mice with hematopoietic-specific caspase-8 ablation
[114]. However, Ripk3-/-Casp8-/- mice infected with ΔYopJ succumbed with kinetics
indistinguishable from mice infected with the parental strain of Yp (Fig 6.1A). These data
suggested that caspase-8-dependent apoptosis does not mediate host survival during
infection with Yersinia.
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We then utilized mice expressing a non-cleavable form of caspase-8 that prevents
caspase-8-mediated apoptosis while preserving caspase-8-mediated cytokine secretion. We
found that the apoptotic conformation of caspase-8 was dispensable for survival as the
kinetics of mortality in Casp8DA/DA and Ripk3-/-Casp8DA/DA mice were indistinguishable
from B6 and Ripk3-/- mice respectively (Fig 6.1B). From these data we concluded that
expression of non-cleavable caspase-8 was sufficient to rescue mice from mortality during
oral Yp infection, implicating caspase-8-mediated cytokine production in host defense
independently of the role of caspase-8 in apoptosis.

6.3.2. Non-cleavable caspase-8 expression correlates with reduced bacterial burdens during
oral infection with Yersinia pseudotuberculosis.
Mice expressing non-cleavable caspase-8 had reduced bacterial burdens in their
Peyer’s Patches, spleens, and livers 2 days post infection (Fig 6.2A, Fig 6.2C and
Fig 6.2D). However, we could observe no difference in mLN bacterial burdens between
any groups of infected mice (Fig 6.2B). Previous work has shown that there are distinct
replicating pools of Yp in the oral model of infection [152]. The spread of bacteria is not a
linear route through Peyer’s Patches to the draining lymph node (mLN), but rather
replication in the Peyer’s patches occurs in parallel to replication in the small intestine.
Bacteria originating from the small intestine disseminate to the spleen and liver directly to
mediate colonization and replication. Therefore, the observed differences in the Peyer’s
Patches are likely due to differences in the first wave of colonization, and the observed
differences in the spleen and liver likely reflect dissemination from the small intestine
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directly. Interestingly, expression of non-cleavable caspase-8 is sufficient to reduce
bacterial burdens during both forms of colonization.

6.3.3. Systemic IL-12p40 is produced independently of caspase-8 expression.
We previously reported that mice with caspase-8 deficiency in their hematopoietic
cells had reduced levels of inflammatory cytokines in their serum 6 days post infection
[114]. Therefore, we were surprised to find that mice, in which caspase-8 is ablated in all
cell populations have wild-type levels of serum IL-12p40 2 days post infection (Fig 6.3).
We interpret these data to mean that caspase-8 expression is not required to mediate
cytokine production in this context Furthermore, we observed no additive effect of the
expression of non-cleavable caspase-8 on a wild-type or RIPK3-null background (Fig 6.3).
We then tested the inflammatory response on a per-cell basis to determine if immune-cell
specific cytokine production was impaired in this context.

6.3.4 Cell-intrinsic IL-12p40 expression occurs independently of caspase-8 expression.
Two innate cell populations that mount the early inflammatory response to Yp are
monocytes and neutrophils [75, 98, 114, 132]. In an effort to measure immune-cell specific
intracellular cytokine responses we selected the mLN, an organ in which bacterial burdens
were statistically indistinguishable amongst the mice used in these studies. We used this
approach to control for differences in immune cell recruitment that can be mediated by
bacterial replication rather than the specific immune state of the host. Using this approach
we found that mLNs isolated from Ripk3-/-Casp8-/- mice had a higher frequency of
IL-12p40 positive monocytes and equivalent cell numbers of IL-12p40 positive monocytes
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when compared to Ripk3-/- controls (Fig 6.4, Fig 6.5A and Fig 6.5B). We also observed a
similar trend in IL-12p40 positive neutrophils (Fig 6.4, Fig 6.6A and Fig 6.6B). These data
were surprising given our findings that caspase-8-deficient hematopoietic cells have a cellintrinsic defect in cytokine production [75]. We interpret these data to mean that caspase8 is not required for IL-12 production in this context.
We also observed greater overall numbers of IL-12p40 positive monocytes in
Ripk3-/-Casp8DA/DA mice, and a higher frequency of IL-12p40 positive monocytes in
Casp8DA/DA mice. One possible explanation for these data were differences in overall
monocyte numbers. Therefore, we measured total inflammatory monocytes in naïve and
infected mice, and found that similar to the phenotype we described in Chapter 4,
Ripk3-/-Casp8DA/DA mice had higher overall numbers of inflammatory monocytes during
infection (Fig 6.7A and Fig 6.7B). These results may provide an explanation for the higher
overall numbers of IL-12p40 positive cells observed in Ripk3-/-Casp8DA/DA mice. We did
not observe a difference in total numbers of monocytes in naïve or infected Casp8DA/DA
mice when compared to B6 controls, suggesting that the higher frequency of IL-12p40
positive cells reflects an increased inflammatory response in these mice (Fig 6.7C and
Fig 6.7D).
There was no additive effect of non-cleavable caspase-8 expression for on a
RIPK3-null background for cytokine production as measured by neutrophil-derived
IL-12p40 production (Fig 6.6). This was surprising given the higher overall neutrophil
numbers we observed at baseline in Ripk3-/-Casp8DA/DA mice (Fig 6.8A). We did observe
an increase in total neutrophil numbers in infected Ripk3-/-Casp8DA/DA mice when compared
to Ripk3-/- controls, but this did not correspond to an increase in total IL-12p40 positive
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neutrophils in these mice (Fig 6.6 and Fig 6.8B). Interestingly, opposite of our observation
in monocytes, non-cleavable caspase-8 on a wild-type background mediated an increase in
overall numbers of IL-12 positive neutrophils, but did not impact frequency (Fig 6.6 C and
Fig 6.6D). We observed a trend toward increased neutrophil infiltrate in the mLNs of
Casp8DA/DA mice at steady-state and during infection, but this was not statistically
significant when compared to B6 controls (Fig 6.8C and Fig 6.8D). Collectively, these
data demonstrate that monocytes and neutrophils produce IL-12p40 independently of
caspase-8 expression; however, in some cases non-cleavable caspase-8 expression can
enhance intracellular cytokine production. In all assays that we used we did not observe
lower levels of global or intracellular cytokine production from Ripk3-/-Casp8-/- mice when
compared to Ripk3-/- controls, indicating that mice lacking global caspase-8 expression
have a distinct phenotype from those lacking caspase-8 expression in just the hematopoietic
compartment.
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6.4 Discussion
We have previously shown that caspase-8 deficiency in hematopoietic cells leads
to acute mortality in response to oral infection with the gram-negative bacterial pathogen
Yersinia pseudotuberculosis (Yp) [114]. Here we demonstrate that complete ablation of
caspase-8 in both hematopoietic and non-hematopoietic cells leads to an even more acute
survival defect in which mice succumb within 4 days of infection. We also observed no
role for caspase-8-dependent apoptosis in this context as these mice were equally
susceptible to an isogenic strain of Yp lacking the effector YopJ (ΔYopJ). Mice with
hematopoietic-specific ablation of caspase-8 largely survive infection with ΔYopJ, but
mice with global ablation of caspase-8 succumb with kinetics indistinguishable from those
infected with Yp expressing YopJ. These data led us to conclude that caspase-8-dependent
apoptosis was dispensable for survival during infection, implicating the cytokine
regulatory function of caspase-8.
Two inflammatory cytokine that are critical for host defense during Yp infection
are TNF and IL-12 [98, 201]. We have previously shown that macrophages derived from
mice expressing a non-cleavable form of caspase-8 produce endogenous levels of
cytokines, but to not undergo YopJ-mediated apoptosis during in vitro Yp infection [75].
We used these mice as a model to test the contribution of caspase-8-mediated cytokine
production specifically, and found that these animals survived oral infection with Yp, and
had reduced bacterial burdens when compared to caspase-8-deficient mice. These data
were consistent with a model in which caspase-8-dependent cytokine production was
required for control of Yp infection in vivo.
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We originally hypothesized that global caspase-8-deficiency would largely
recapitulate our observations with hematopoietic-specific ablation of caspase-8. However,
we were surprised to find that mice lacking caspase-8 had no defect in serum cytokines or
intracellular cytokine production in innate immune cells. Expression of non-cleavable
caspase-8 was sufficient to reduce bacterial burdens and mediate survival; however, this
effect appears to be independent of caspase-8-mediated cytokine secretion. Caspase-8deficient mice, and mice expressing non-cleavable caspase-8, largely had no detectible
differences in serum cytokines or intracellular cytokine production by monocytes or
neutrophils. We interpret these data to mean that caspase-8 expression is not required for
the early cytokine response to Yp. Intriguingly, these data suggested that there is an
alternative role for caspase-8 in regulating bacterial dissemination or replication
independently of cell death or cytokine secretion.
One possible explanation for the discrepancy between mice with total caspase-8
ablation and mice with hematopoietic-specific ablation is developmental differences
between these mice. There are no reported developmental defects in the intestines of Ripk3/-

Casp8-/- mice. However, this may be due to the focus on the immune compartment of

these mice as they display acute lymphoproliferative disease [104, 105]. We have
previously implicated caspase-8 in pro-inflammatory gene expression in macrophages
downstream of TLR signaling, but it is possible that it interacts with some of these
signaling intermediates in other cell types such as intestinal epithelial cells. Homeostatic
turnover of intestinal epithelial cells is primarily mediated by TNF signaling, which is
upstream of caspase-8 activation [203]. Additionally, mice deficient in TAK1 or the
transcription factor p65 in their intestinal epithelium have increased ROS production and
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intestinal apoptosis respectively [203, 204]. c-Rel has also been implicated in epidermal
homeostasis through the regulation of cell cycle genes [205], but it is also possible that this
regulation also occurs in intestinal epithelial cells. In Chapter 2 we note that caspase-8
deficiency leads to impaired expression of cell cycle genes in macrophages in response to
TLR stimulation. Therefore, it would be interesting to see if caspase-8 and c-Rel also play
a role in intestinal epithelial cell homeostasis. If caspase-8 mediates development of the
small intestine or barrier integrity during steady-state then the survival defect we observed
in mice globally deficient in caspase-8 may be due to failure to control bacterial
dissemination from the small intestine. Expression of non-cleavable caspase-8 may be
sufficient to maintain barrier integrity, in turn promoting survival of the host. Future studies
that interrogate the role of caspase-8 in intestinal epithelial cell homeostasis and barrier
integrity may help elucidate the mechanism of caspase-8-dependent protection during oral
infection with Yp. Collectively, these studies show, for the first time, that caspase-8 nonapoptotic activity is sufficient to mediate survival during Yp infection, and that this
protection occurs independently of the cytokine regulatory function of caspase-8 (Fig 6.9).
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6.5 Figures

Fig 6.1. Non-cleavable caspase-8 promotes host survival during oral infection with
Yersinia pseudotuberculosis.
(A) Survival of B6, Ripk3-/-, and Ripk3-/-Casp8-/- mice (n=10-11) infected o.g. (3-4x10^8
CFU/mouse) with Yersinia pseudotuberculosis (IP2777) and ΔYopJ Yersinia
pseudotuberculosis (IP2777).
(B) Survival of B6, Ripk3-/- , Ripk3-/-Casp8-/-, Ripk3-/-Casp8DA/DA, and Casp8DA/DA mice
(n=10) infected o.g. (4x10^8 CFU/mouse) with Yersinia pseudotuberculosis (IP2777)
Mantel-cox test ( n.s. not significant , **** p<0.0001). Panel (A) and (B) performed once.
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Fig 6.2. Non-cleavable caspase-8 expression correlates with reduced bacterial burdens
during oral infection with Yersinia pseudotuberculosis.
Bacterial burdens in the Peyer’s Patches (A), mLNs (B), spleens (C) and livers (D) of B6,
Ripk3-/-, Ripk3-/-Casp8-/-, Ripk3-/-Casp8DA/DA, and Casp8DA/DA mice infected o.g. (2-3x10^8
CFU/mouse) with Yersinia pseudotuberculosis (IP2777) 2 days post-infection. Each circle
represents a mouse.
Student’s two-tailed unpaired t-test (n.s. not significant, *p<0.05, **p<0.01,
*** p<0.001). Error bars indicate ± SEM. Data pooled from two independent experiments.
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Fig 6.3. Systemic IL-12p40 is produced independently of caspase-8 expression.
ELISA measurement of serum IL-12p40 from B6, Ripk3-/-, Ripk3-/-Casp8-/-,
Ripk3-/-Casp8DA/DA, and Casp8DA/DA mice infected o.g. (2-3x10^8 CFU/mouse) with
Yersinia pseudotuberculosis (IP2777) 2 days post-infection. Each circle represents a
mouse.
Student’s two-tailed unpaired t-test (n.s. not significant). Error bars indicate ± SEM. Data
pooled from two independent experiments.
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Fig 6.4. Flow-cytometry gating strategy for innate immune populations during oral
infection with Yersinia pseudotuberculosis.
Representative

flow

contour

(CD45+Lin-CD11b+Ly6G+)

and

plots

of

the

inflammatory

gating

strategy

monocytes

for

neutrophils

(CD45+Lin-CD11c-

Ly6ChiMHCII+) in the mLN of a B6 mouse infected o.g. (3x10^8 CFU/mouse) with
Yersinia pseudotuberculosis (IP2777) 2 days post-infection. All samples pre-gated on live
single cells. Lin markers (CD3, B220).
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Fig 6.5 Monocyte IL-12p40 expression is independent of caspase-8.
(A) Frequency and (B) total numbers of IL-12p40+ inflammatory monocytes in the mLNs
of Ripk3-/-, Ripk3-/-Casp8-/-, and Ripk3-/-Casp8DA/DA mice infected o.g. (3x10^8
CFU/mouse) with Yersinia pseudotuberculosis (IP2777) 2 days post-infection. Each circle
represents a mouse.
(C) Frequency and (D) total numbers of IL-12p40+ inflammatory monocytes in the mLNs
of B6 and Casp8DA/DA mice infected o.g. (3x10^8 CFU/mouse) with Yersinia
pseudotuberculosis (IP2777) 2 days post-infection. Each circle represents a mouse.
Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05, **<0.01,
*** p<0.001). Error bars indicate ± SEM. Data representative of two independent
experiments.
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Fig 6.6. Neutrophil IL-12p40 expression is independent of caspase-8.
(A) Frequency and (B) total numbers of IL-12p40+ neutrophils in the mLNs of Ripk3-/-,
Ripk3-/-Casp8-/-, and Ripk3-/-Casp8DA/DA mice infected o.g. (3x10^8 CFU/mouse) with
Yersinia pseudotuberculosis (IP2777) 2 days post-infection. Each circle represents a
mouse.
(C) Frequency and (D) total numbers of IL-12p40+ neutrophils in the mLNs of B6 and
Casp8DA/DA mice infected o.g. (3x10^8 CFU/mouse) with Yersinia pseudotuberculosis
(IP2777) 2 days post-infection. Each circle represents a mouse.
Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05, **<0.01,
*** p<0.001). Error bars indicate ± SEM. Data representative of two independent
experiments.
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Fig 6.7 RIPK3-null mice expressing non-cleavable caspase-8 have higher levels of
monocyte infiltration during Yersinia pseudotuberculosis infection.
(A) Total numbers of monocytes in the mLNs of naïve Ripk3-/-, Ripk3-/-Casp8-/-, and
Ripk3-/-Casp8DA/DA mice. Each circle represents a mouse.
(B) Total numbers of monocytes in the mLNs of Ripk3-/-, Ripk3-/-Casp8-/-, and
Ripk3-/-Casp8DA/DA

mice

infected

o.g.

(3x10^8

CFU/mouse)

with

Yersinia

pseudotuberculosis (IP2777) 2 days post-infection. Each circle represents a mouse.
(C) Total numbers of monocytes in the mLNs of naïve B6 and Casp8DA/DA mice. Each
circle represents a mouse.
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Fig 6.7 Continued: (D) Total numbers of monocytes in the mLNs of B6 and Casp8DA/DA
mice infected o.g. (3x10^8 CFU/mouse) with Yersinia pseudotuberculosis (IP2777) 2 days
post-infection. Each circle represents a mouse.
Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05, **<0.01). Error bars
indicate ± SEM. Panels (A) and (C) are each pooled from two independent experiments.
Panels (B) and (D) are each representative of two independent experiments.
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Fig 6.8 RIPK3-null mice expressing non-cleavable caspase-8 have higher neutrophil
numbers at steady-state.
(A) Total numbers of neutrophils in the mLNs of naïve Ripk3-/-, Ripk3-/-Casp8-/-, and
Ripk3-/-Casp8DA/DA mice. Each circle represents a mouse.
(B) Total numbers of neutrophils in the mLNs of Ripk3-/-, Ripk3-/-Casp8-/-, and Ripk3-/Casp8DA/DA mice infected o.g. (3x10^8 CFU/mouse) with Yersinia pseudotuberculosis
(IP2777) 2 days post-infection. Each circle represents a mouse.
(C) Total numbers of neutrophils in the mLNs of naïve B6 and Casp8DA/DA mice. Each
circle represents a mouse.
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Fig 6.8 Continued: (D) Total numbers of neutrophils in the mLNs of B6 and Casp8DA/DA
mice infected o.g. (3x10^8 CFU/mouse) with Yersinia pseudotuberculosis (IP2777) 2 days
post-infection. Each circle represents a mouse.
Student’s two-tailed unpaired t-test (n.s. not significant, * p<0.05). Error bars indicate ±
SEM. Panels (A) and (C) are each pooled from two independent experiments. Panels (B)
and (D) are each representative of two independent experiments.
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Fig 6.9. Graphical abstract and future directions: Caspase-8 promotes host survival during
oral infection with Yersinia pseudotuberculosis independently if its cytokine regulatory or
apoptotic functions.
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CHAPTER 7: Discussion and future directions.
7.1 Summary of findings
In this study we hypothesized that caspase-8 enzymatic activity would play a role
in inflammatory gene expression independently of its apoptotic function, and that
caspase-8-mediated inflammatory gene regulation would be required for host defense
against a variety of pathogens in vivo. In Chapter 2 we identified the mechanism by which
caspase-8 regulates the inflammatory cytokines IL-12 and IL-1β through the NF-κB family
member c-Rel. We also showed that expression of c-Rel in caspase-8-deficient
macrophages is sufficient to restore production of both IL-12 and IL-1β. In Chapter 3 we
tested the role for caspase-8 enzymatic activity in c-Rel translocation and inflammatory
gene expression. We found that both the enzymatic and non-enzymatic functions of
caspase-8 mediate c-Rel translocation and expression of caspase-8-dependent
inflammatory genes. These results help address a long-standing conflict in the field
regarding the relative contributions of caspase-8 enzymatic and non-enzymatic activity to
gene expression.
In Chapter 4 we defined a role for caspase-8 apoptotic activity and RIPK3mediated programed necrosis in steady-state levels of myeloid cell populations in
secondary lymphoid organs. These data implicate caspase-8 in innate immune cell turnover
for the first time. In Chapter 5 we identified a role for caspase-8-mediated cytokine
secretion in host defense during acute infection with the eukaryotic pathogen Toxoplasma
gondii. To our knowledge this is the first report of caspase-8 mediating host survival
against a eukaryotic pathogen in vivo. In Chapter 6 we identified a role for caspase-8 in
host survival during infection with the gram-negative enteric pathogen Yersinia
pseudotuberculosis. We found that survival during Yersinia infection was mediated
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independently of caspase-8-dependent apoptosis and caspase-8-dependent proinflammatory cytokine production. These data potentially implicate caspase-8 in
maintenance of intestinal barrier integrity for the first time. Collectively, these studies
highlight the broad role for caspase-8 in immune homeostasis as well as host defense.
Moreover, they suggest that many functions of caspase-8 are independent of caspase-8mediated apoptosis.
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7.2 Key findings of this work
7.2.1 Distinct regulation of the NF-κB family members p65 and c-Rel is mediated, in part,
through caspase-8.
Our data implicate caspase-8 in the distinct regulation of c-Rel and p65 in response
to TLR stimulation. Early work described a restricted role for c-Rel in Il12b expression in
macrophages [71]. However, our data identified many caspase-8-dependent genes that
were also dependent on the expression of c-Rel, potentially implicating c-Rel in the
regulation of other genes in response to TLR activation. The mechanisms by which c-Rel
and p65 are distinctly regulated in macrophages has yet to be elucidated; however, it is
possible that caspase-8 represents one mechanism to orchestrate their distinct activation.
NF-κB family-member regulation can be categorized as either

canonical and non-

canonical NF-κB signaling pathways that mediate differential regulation of p65 and RelB
respectively [206-209]. The classification of canonical and non-canonical NF-κB signaling
is largely based on the differential utilization of NEMO and IKKα respectively [210, 211].
While entirely speculative, it is possible that in macrophages differential activation of cRel and p65 can be characterized based on the utilization of caspase-8.
We also observed a selective effect of caspase-8-dependent IKKα/β
phosphorylation on the degradation of IκBε. IκBε is thought to preferentially associate with
both p65 and c-Rel, and recent evidence describes a role for IκBε/c-Rel specific
interactions in certain cell-types [176, 212]. Like other IκB proteins, IκBε is degraded by
the ubiquitin-26S proteasome pathway [57, 58]. However, IκBε can also be degraded by
the REGγ proteasome in non-hematopoietic cells in vivo [213]. These data suggest there
may be other mechanisms of IκBε regulation that are independent of IKK-mediated
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degradation. Previously uncharacterized mechanisms of proteasomal degradation may
provide an explanation for the distinct regulation of IκBε and IκBα in a caspase-8-deficient
setting. Further experiments to test the hypothesis that there is preferential association
between c-Rel and IκBε in macrophages will help elucidate how p65 and c-Rel are
distinctly regulated in this context. Testing the biochemical sensitivities of the IκB proteins
to differing levels of IKK phosphorylation may also provide insight into the seemingly
increased sensitivity of IκBε to perturbations in IKKα/β phosphorylation. Other studies
have primarily focused on the temporal regulation of IκB protein expression [59], but these
do not address the threshold of IKKα/β activation required to mediate the degradation of
IκB proteins.
One looming question from these studies is how exactly caspase-8 regulates IKK
activation. We could find no role for caspase-8 in the activation of the upstream kinases
TAK1 or TBK1 that are classically thought to promote IKK activation [211, 214, 215].
One possible explanation may be the specific requirement for NIK (Mitogen-activated
protein kinase kinase kinase kinase 4) in this signaling pathway. NIK is activated in
response to both CD40 and TNF to promote IKK phosphorylation [207, 209]. One caveat
to this hypothesis is that NIK is constitutively degraded by TRAF3 at steady state, and the
kinetics of TRAF3 degradation and NIK activation may not be concordant with the role of
caspase-8 in the rapid response to TLR stimulation. However, it is still possible that NIK
plays a role in our system; therefore, we will test the impact of caspase-8 on NIK activation
specifically, which may help elucidate the mechanism by which caspase-8 mediates IKK
activation.
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7.2.2 Caspase-8 regulates inflammatory gene expression through both its enzymatic and
non-enzymatic activity.
In Chapter 3 we demonstrated a role for caspase-8 enzymatic activity in the
expression of pro-inflammatory cytokines in response to both TLR4 and TLR9 activation.
These data provoke the hypothesis that caspase-8 regulates inflammatory gene expression
through its cleavage activity. A candidate substrate for caspase-8 would need to meet two
key requirements: (1) the substrate would need to be cytoplasmic, as caspase-8 has no NLS
and is not known to localize to the nucleus; additionally, (2) the caspase-8 substrate is likely
a negative regulator of IKK activation based on the finding that inhibition of caspase-8
enzymatic activity reduced IKK phosphorylation to the same magnitude observed in
caspase-8-deficient cells. Earlier in this project we tested several potential caspase-8
targets, including HDAC7 and EHMT1, which have both cytoplasmic and nuclear
localization as well as putative caspase-8-cleavage sites. However, these proteins are much
more distal to TLR stimulation than IKK phosphorylation [216-218], and—perhaps not
surprisingly—inhibition of HDAC7 or EHMT1 was not sufficient to restore inflammatory
cytokine transcription in caspase-8-deficient cells (data not shown). Another logical
candidate for caspase-8 cleavage is the linear deubiquitinase CYLD which cleaves K63
ubiquitin on RIPK1 [133]. Ubiquitination of RIPK1 is known to mediate expression of prosurvival genes during TNFR activation through the recruitment of NEMO, IKKα, and
IKKβ [106, 107]. However, siRNA knock down of CYLD was not sufficient to restore
cytokine secretion in caspase-8-deficient cells (data not shown).
Although these data are not conclusive, they suggest there is a cytoplasmic target
of caspase-8 that has yet to be identified. Recently caspase-8 has been implicated in
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maintenance of chromosome stability through the cleavage of Polo-like kinase 1 (PLK1) a
mediator of centrosome assembly and spindle maturation during the M-phase of cell
division [219]. Given our findings regarding the role of caspase-8 in cell cycle gene
regulation (Chapter 2), it is tempting to speculate that PLK1 may play a previously
uncharacterized role in TLR-induced inflammation in macrophages. We are interested in
testing the impact of PLK1 inhibition during TLR stimulation in caspase-8-deficient
macrophages. We hypothesize that if PLK1 is a target of caspase-8 in response to TLR
stimulation then inhibition of PLK1 should be sufficient to restore inflammatory cytokine
transcription in caspase-8-deficient cells. It is also possible that caspase-8 cleaves PLK1 in
macrophages, but this cleavage does not mediate inflammatory gene expression. However,
PLK1 cleavage may be the primary mechanism of caspase-8-mediated cell cycle gene
regulation during TLR stimulation. Regardless of the outcome of these experiments we
will gain further insight into the diverse array of caspase-8 cleavage targets during TLR
stimulation.
Another set of experiments we are interested in performing are unbiased proteomics
to identify novel caspase-8 cleavage targets. This approach would utilize a method known
as TAILS (Terminal amine isotopic labeling of substrates) which identifies novel N-termini
through TMT labeling [220]. We hypothesize that caspase-8-sufficent macrophages will
have specific N-termini that are absent in caspase-8-deficient cells upon TLR stimulation.
This approach would allow us to identify a variety of caspase-8 substrates, and combine
this data with our knowledge regarding caspase-8 and IKK activation to identify potential
candidates for further analysis.
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7.2.3 Caspase-8 regulates cell cycle gene expression in response to multiple TLRs.
The most surprising result to emerge from these studies was the finding that
caspase-8 deficiency leads to a defect in cell cycle gene expression during TLR stimulation
(Chapter 2). Expression of cell cycle-related genes was impaired in caspase-8-deficient
cells during both TLR4 and TLR9 stimulation (Fig 2.2B and Fig 2.2D). These data were
particularly interesting in light of recent evidence that caspase-8 cleaves PLK1 a mediator
of centrosome assembly and spindle maturation during the M-phase of cell division [219].
The study describing caspase-8-mediate cleavage of PLK1 was conducted in tumorderived cell lines as well as mouse embryonic fibroblasts (MEFs); therefore, these data
may not be generalizable to all cell types. However, there is evidence that c-Rel regulates
cell cycle progression in B cells [221, 222], potentially implicating c-Rel, PLK1, and
caspase-8 in cell cycle gene regulation. Collectively, these studies lead us to hypothesize
that PLK1 may play a role in cell cycle gene expression in macrophages. To test this
hypothesis we plan to inhibit and transiently ablate PLK1 in caspase-8-deficient
macrophages. Our expectation is that loss of PLK1 function will be sufficient to restore
cell cycle gene expression in caspase-8-deficient cells. We will further test the ability of
caspase-8 to cleave PLK1 directly to determine if PLK1 is a substrate of caspase-8 during
TLR activation.
Another potential area of investigation is the impact of caspase-8 on cell cycle
progression myeloid in cell populations such as monocytes. We hypothesize that caspase-8
cleavage of PLK1 would promote differentiation of monocytes in response to TLR
stimulation. TLR activation is known to induce monocyte differentiation into macrophages
[223], and caspase-8 may be one mechanism that promotes this rapid differentiation. Our
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future investigations will focus on elucidating the mechanism by which caspase-8 regulates
cell cycle gene expression in a TLR-dependent manner.
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7.2.4 Caspase-8-dependent apoptosis, and RIPK3-mediated programmed necrosis may
regulate steady-state numbers of myeloid cells.
In an effort to elucidate the contribution of caspase-8-mediated cytokine production
in vivo, we generated a mouse in which the apoptotic conformation of caspase-8 is rendered
unstable while preserving its cytokine regulatory function (Casp8DA/DA) [75]. Caspase-8 is
also known to negatively regulate another cell death pathway known as RIPK3-mediated
programed necrosis [104, 105]. Mice deficient in caspase-8 do not survive embryonic
development because of the de-repression of programed necrosis. Dual ablation of
caspase-8 and RIPK3 rescues mice from embryonic lethality. We further crossed
Casp8DA/DA mice onto a RIPK3-null background to facilitate direct comparison between
mice completely lacking caspase-8, and mice lacking caspase-8 apoptotic activity
specifically. Ripk3-/-Casp8-/- mice display a lymphoproliferative disease that is similar to
that observed in mice lacking Fas or FasL, and this phenotype is attributed the inability of
Ripk3-/-Casp8-/- mice to undergo caspase-8-mediated apoptosis [104, 105]. Therefore, we
hypothesized that mice expressing non-cleavable caspase-8 on a RIPK3-null background
would also display a similar lymphoproliferative disease.
We were surprised to find that Ripk3-/-Casp8DA/DA mice had a distinct phenotype
from Ripk3-/-Casp8-/- mice. Ripk3-/-Casp8DA/DA mice had morphological defects in splenic
architecture, and an accumulation of myeloid cells in secondary lymphoid organs (Chapter
4). At steady-state we could not observe an increase in total myeloid cell numbers in
Ripk3-/-Casp8-/- mice (Chapter 6), suggesting that the accumulation of myeloid cells is a
unique feature of mice expressing non-cleavable caspase-8. Furthermore, we did not detect
a statistical difference in myeloid populations in the mLNs of B6 and Casp8DA/DA mice.
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(Chapter 6). We interpret these data to mean that the phenotype of Ripk3-/-Casp8DA/DA
mice is dependent on both the expression of non-cleavable caspase-8 and
RIPK3-deficiency. These data implicate caspase-8 in another mechanism of immune cell
homeostasis that is entirely dependent on its apoptotic activity. Further studies that identify
the time of onset of myeloid accumulation in Ripk3-/-Casp8DA/DA mice, as well as the origin
of this myeloid cell population, will provide insight into the role caspase-8-mediated
apoptosis plays in myeloid circulation at steady-state.
These data provoke the hypothesis that caspase-8-mediated apoptosis plays a
cell-intrinsic role in turnover of myeloid cell populations in the periphery. An approach
that utilizes reciprocal bone marrow chimeras in which we transfer Ripk3-/-Casp8DA/DA
hematopoietic cells into Ripk3-/-Casp8-/- mice will help us determine if cell-intrinsic
expression of non-cleavable caspase-8 in hematopoietic cells is sufficient to mediate this
phenotype. Moreover, we should observe no accumulation of these cell populations in
Ripk3-/-Casp8DA/DA reconstituted with Ripk3-/-Casp8-/- bone marrow as complete caspase-8
ablation appears sufficient to protect mice from the accumulation of myeloid cells. It is
also possible the observed phenotype in Ripk3-/-Casp8DA/DA mice is due to non-cleavable
caspase-8-mediated expression of chemokines that promote myeloid cell egress from the
bone marrow. We have shown a role for caspase-8 in the expression of Cxcl2 in
macrophages in response to TLR stimulation (Chapter 2). The chemokine CXCL2
mediates myeloid cell egress from the bone marrow via CCR2 [224]. Therefore, it is
possible that caspase-8-dependent CXCL2 promotes myeloid cell egress, but there is no
cell turnover in the periphery due to a defect in caspase-8-dependent apoptosis. To test the
contribution of caspase-8-mediated CXCL2 secretion we would generate mixed bone
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marrow chimeras in which Ripk3-/-Casp8DA/DA mice are reconstituted with Ccr2-/- bone
marrow, with the expectation that this will abrogate myeloid accumulation in the periphery.
These proposed experiments will help to elucidate the mechanism of myeloid cell
accumulation in Ripk3-/-Casp8DA/DA mice at steady-state.
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7.2.5. Caspase-8 mediates host survival during infection with Toxoplasma gondii.
Others have described a role for caspase-8-mediated cytokine production in
response to fungal and bacterial pathogens in vitro as well bacterial pathogens in vivo [75,
77, 100, 110, 147]. To our knowledge, our studies are the first to implicate caspase-8 in
host defense during infection with Toxoplasma gondii (Chapter 5). The mechanism of
caspase-8-mediated resistance to T. gondii is likely through its cytokine regulatory
function. Caspase-8-deficient DCs had impaired intracellular IL-12 production, and
caspase-8-deficient animals had impaired recruitment of inflammatory monocytes into the
site of infection. Moreover, caspase-8-deficient mice could be completely rescued through
endogenous injection of IL-12. These data, while correlative, suggest a cell-intrinsic role
for caspase-8-mediated cytokine production in vivo in response to T. gondii. To directly
test the contribution of caspase-8-mediated IL-12 production in DCs we plan to generate
mixed bone marrow chimeras with congenically labeled bone marrow from Ripk3-/-Casp8/-

and Zbtb46-cre IRF8-floxed mice—in which conventional type 1 dendritic cells are

selectively ablated [197]. Transferring this mixed bone barrow into a sublethally irradiated
Ripk3-/-Casp8-/- host will allow us to determine if intracellular production of IL-12 in Ripk3/-

Casp8-/- DCs is rescued by caspase-8-sufficient bone marrow via bystander effects, or if

caspase-8-deficient DCs still have impaired IL-12 production. The later result would
suggest a cell-intrinsic defect in cytokine production.
Another area of investigation is the role of caspase-8 in host defense during
infection with another Apicomplexan parasite: Cryptosporidium. parvum. Infection with
Cryptosporidium spp. causes severe developmental delays in infected children with the
highest prevalence rate in developing countries [225, 226]. It has only recently become
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possible to passage these parasite in tissue culture to facilitate infection of different strains
of immunocompromised mice [198]. Little is known about the mechanism of host defense
against C. parvum or the mechanism of C. parvum antagonism of the immune system.
Given the role of caspase-8 in protecting mice against the related pathogen T. gondii it is
plausible that caspase-8 plays a similar role during C. parvum infection. Caspase-8 likely
plays a much more extensive role in defense against bacterial, fungal, and protozoan
pathogens through both its apoptotic and cytokine regulatory functions, and we hope the
studies described in Chapter 5 serve as a basis for further investigation into
caspase-8-mediated host defense.
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7.2.6 Caspase-8 may play a role in intestinal epithelial cell homeostasis at steady-state and
during infection.
In Chapter 6 we show that global ablation of caspase-8 and hematopoietic-specific
ablation of caspase-8 have distinct impacts on the inflammatory response to the
gram-negative bacterial pathogen Yersinia pseudotuberculosis (Yp). Hematopoieticspecific ablation of caspase-8 leads to acute host mortality, increased bacterial burdens,
and impaired inflammatory response during oral infection with Yp. Global ablation of
caspase-8 results in acute host mortality, and higher systemic bacterial burdens, but no
impairment in inflammatory cytokine production. Moreover, caspase-8 apoptotic activity
seems to be dispensable for Yp-protection in this context. Expression of non-cleavable
caspase-8 was sufficient to reduce bacterial burdens and limit host mortality. These data
suggest that caspase-8 may play a role in non-hematopoietic cells that is independent of
both its cytokine regulatory function and apoptotic function. These results led us to
hypothesize that caspase-8 plays a role in epithelial cell turnover in the small intestine.
The systemic dissemination we observed two days post infection in
caspase-8-deficient animals may be mediated by a disruption in barrier integrity in the
small intestine. Previous groups have shown that colonization of livers and spleens in
Yp-infected animals is mediated by bacterial translocation directly from the small intestine.
It is tempting to speculate that the role of caspase-8 in cell cycle gene expression may be a
common function of caspase-8 in other cell types, including intestinal epithelial cells.
Recent data has shown that mouse embryos lacking caspase-8 have defects in mitotic
alignment in their colons, skin, and livers [219]. Immunohistochemical analysis of the
small intestine of caspase-8-deficient and caspase-8-sufficient animals at steady-state, and
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during Yp infection, will help us test the hypothesis that caspase-8 mediates barrier
integrity. We would also like to perform live imaging of 3D organoid cultures derived from
Ripk3-/-, Ripk3-/-Casp8-/-, and Ripk3-/-Casp8DA/DA mice to test the hypothesis that caspase-8
regulates cell division in this context [227]. Caspase-8 expression is dysregulated in
tumorigenic tissue [182], and previous work has largely focused on the impact that this
disruption has on apoptosis of tumorigenic cells [228, 229]. However, recent data that
demonstrate a role for caspase-8 in cell cycle progression [219] suggest that caspase-8 has
multiple roles in the prevention of tumor development, potentially expanding the viable
caspase-8 targets during tumor therapy.
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7.3 Concluding remarks
The mechanisms that govern the spectrum of immune activation have far reaching
implications for human disease. Chronic inflammation leads to diseases that have become
globally pervasive: inflammatory bowel disease, diabetes, and heart disease among others.
And prolonged immune suppression leads to the outgrowth of tumorigenic cells and
chronic infection. In these studies we have implicated caspase-8 as a protein that regulates
the magnitude of immune activation during infection. We have shown that caspase-8
enzymatic activity contributes to both cell death and cell-intrinsic cytokine production.
Moreover, it is likely that in a heterogenous environment in vivo caspase-8 promotes both
cell death and cytokine secretion in distinct cells to ultimately facilitate pathogen clearance
while dictating the appropriate level of immune activation. We propose that caspase-8
serves as a regulatory node to integrate both cell-death-inducing and pro-inflammatory
stimuli, in turn mediating a rapid intracellular response that is dependent on the
extracellular environment. In this way, a given cell is rapidly poised to undergo either cell
death or secrete inflammatory mediators, but ultimately the context of the environment
dictates the final outcome. It is clear from the studies described here as well as emerging
literature that cell death and inflammation are intrinsically linked. We hope that the data
described in this thesis begin the process of supplanting models in which inflammation and
cell death are easily separable pathways with a new model in which there is an appreciation
for the integration between these two essential biological processes.
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CHAPTER 8: Materials and Methods
8.1 Experimental Model and Subject Details
8.1.1 Mice
C57BL/6 mice were obtained from Jackson Laboratories. The Ripk3-/-Casp8-/- mice
and Mlkl-/-Fadd-/- mice used in these studies have been described previously [105, 127],
and were provided by Doug Green (St. Jude Children’s Research Hospital). Ripk3-/- mice
were provided by Vishva Dixit (Genentech). Il12b-/- mice were previously described and
provided by the Hunter lab [230]. Rel-/- mice were generated and provided by Hsiou-chi
Liou [231]. Casp8DA/DA mice were previously described [75]. These mice were further
crossed onto Ripk3-/- mice for 8 generations. For animal experiments, age- and sex-matched
8-12-week old mice were used.
All animal studies were performed in compliance with the federal regulations set
forth in the Animal Welfare Act (AWA), the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of Health, and the guidelines of
the University of Pennsylvania Institutional Animal Use and Care Committee. All
protocols used in this study were approved by the Institutional Animal Care and Use
Committee at the University of Pennsylvania (Multiple Project Assurance # A3709-01,
Protocol #804523, Protocol #805045).
8.1.2. Toxoplasma gondii
Transgenic Pru-tdTomato parasites were generated as previously described [232].
Parasites were maintained in vitro in a 37°C 5% CO2 humidified incubator by serial
passage through human foreskin fibroblasts in DMEM supplemented with 20% M199,
10% fetal bovine serum, 1% pencillin-streptomycin,
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and 25 μg/ml gentamicin.

Tachyzoites were prepared for infection by serial needle passage and filtered through a 5μm pore-size filter. Mice were infected i.p. with 104 live, invasion-competent parasites.

8.1.3. Yersinia pseudotuberculosis
Mice were fasted for 12–16 hours and infected orally with 2–4 x 108 Yersinia
(32777) or ΔYopJ (32777) as indicated. Mice were monitored for survival or sacrificed
and tissues were harvested 2 days post-infection, as indicated. Bacterial load was
determined by plating dilutions of tissue homogenates on LB+irgasan plates, serum
cytokines were measured using ELISA, and single-cell analysis was performed by flow
cytometry.
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8.2 Method Details
8.2.1 Bone marrow chimeras
6-week-old female B6.SJL mice were sublethally irradiated with 1100 rads. Mice
were injected with 2-5x106 cells from bone marrow isolated from B6, Il12b-/-, Ripk3-/-,
Ripk3-/-Casp8-/- mice 6hrs post irradiation. Mice were given Sulfatrim in their water for 3
weeks. Infections were performed 10-12 weeks after irradiation and reconstitution.

8.2.2 BMDM electoporation and hc-Rel plasmid
Bone marrow derived macrophages (BMDMs) were grown as described in section
8.2.4. Cells were harvested from petri-dishes in 4°C PBS without calcium and magnesium.
Cells were electroporated using the Amaxa’s nucleofection procedure using 9 million
BMDMs and 12ug of plasmid per condition. hc-Rel IRES-GFP containing plasmid and
empty vector controls were made on a modified pBent2 plasmid. The plasmid cloning
method has been previously described [50], and plasmids were purified prior to
electroporation using the Qiagen Plasmid Maxi Kit.

8.2.3 Caspase-8 activity assay
BMDMs were pre-treated for 1hr with zVAD-fmk (100 μM SM Biochemicals) and
stimulated with LPS (E.coli O55: B5 LPS Sigma, 100 ng/mL) or 1 μM CpG (IDT) for
30min or staurosporine (10 μM Sigma) for 3.5hrs. Caspase-8 activity was measured using
the Caspase-8 fluorometric assay kit (Enzo, #ALX-850-222-K101). Fluorescence was read
30 minutes after substrate incubation per kit instructions.
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8.2.4 Cell culture
BMDMs were grown as previously described [202] in a 37°C 5% CO2 humidified
incubator in DMEM supplemented with 10% FBS, HEPES, sodium pyruvate (completeDMEM) and 30% L929 supernatant for 7–9 days. 16–20 hrs prior to treatment cells were
re-plated into 96-, 48-, 24-, 12- or 6-well dishes in complete-DMEM containing 10% L929
supernatant. Cells were incubated at 37°C post-stimulation. zVAD-fmk (100 μM) or IETDfmk (500 μM SM Biochemicals) was added 1 hr prior to treatment with LPS (100 ng/mL)
or CpG (1μM). The generation of immortalized cells and retroviral transduction were
previously described [114].
8.2.5 ChIP-qPCR
BMDMs were stimulated with LPS (100ng/mL) for indicated time points. Cells
were cross linked with disuccinimidyl glutarate (Thermo Fisher) and formaldehyde
(Sigma). Nuclear lysis was performed with the truChIP Chromatin Shearing Reagent KIT
(Covaris) and nuclei were sonicated using the Covaris S220 sonicator. Chromatin was
immunoprecipitated using anti-p65 antibody (sc-372X Santa Cruz) and anti-c-Rel antibody
(sc-71X Santa Cruz) and protein G agarose beads (Millipore). All samples were column
purified with the QIAquick PCR purification Kit (Qiagen). qPCR was performed using
SYBER Green PCR Master Mix (Thermo Fisher) with 45 cycles of 95˚C(15s), 60˚C(30s)
and 72˚C(30s). Primer pairs were designed to amplify 80-250 bp fragments of the promoter
region of each gene and melt curve analysis was used to confirm the amplification of
unique products. Primer sequences used are listed in the Appendix.
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8.2.6 Confocal Microscopy
BMDMs were seeded on round, glass coverslips in 24-well plates and allowed to
adhere overnight. BMDMs were pre-treated for 1hr zVAD-fmk (100 μM) where indicated
and stimulated with LPS (100 ng/mL) or CpG 1 μM CpG for 2hrs. BMDMs were fixed
with 4% PFA, permeabilized with 0.2% Triton, and blocked in 10% BSA. BMDMs were
incubated with p65 (CST #8242, 1:200) and c-Rel(Santa Cruz #365720, clone G-7, 1:25)
primary antibodies for 2 hours at 37°C, 5% CO2 in 4% BSA. BMDMs were washed in PBS
and incubated with Alexa Fluor rabbit 488 (Thermo Fisher, 1:5000) and Alexa Fluor mouse
488 (Thermo Fisher, 1:5000) at room temperature for 1 hour in 4% BSA. BMDMs were
washed in PBS and stained with Hoechst (Fisher Scientific, 1:2500) and Alexa Fluor 647
Phalloidin (Thermo Fisher, 1:50) for 30 min in PBS at RT. Coverslips were washed,
mounted on glass slides with Fluoromount-G (Thermo Fisher) and dried overnight at RT.
Slides were imaged on a Leica SP5-II Confocal/FLIM Microscope at 63x. Three single
image slices each containing 20-50 cells were taken for each genotype and condition. Cells
imaged for display were imaged at an additional 2.5x. The brightness and contrast of
display images were enhanced equally across genotypes using ImageJ, with each channel
enhanced separately using secondary only, Rel-/- BMDMs, and unstained controls. Images
used for quantification were not altered. Nuclear and cytoplasmic intensity of c-Rel and
p65 was analyzed with the Multi Wavelength Cell Scoring application within MetaMorph
version 7.8 (Molecular Devices Corporation, San Jose, CA). 60-150 cells were analyzed
per genotype and condition.
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8.2.7 Cytospins
150,000 peritoneal exudate cells were centrifuged at 1000 rpm onto glass
microscope slides for 5 min. Slides were dried for 1hr in the dark. Slides were stained with
Giemsa May-Grünwald reagents (Sigma). Slides were dried overnight and sealed. 500 cells
were counted per slide.
8.2.8 ELISA (in vitro)
BMDMs were pre-treated for 1hr with IETD-fmk (500 μM) or zVAD-fmk (100
μM) where indicated and stimulated with 100 ng/mL E. coli LPS (Sigma) or 1 μM CpG
(IDT) for 5 hours unless otherwise indicated. Release of proinflammatory cytokines was
measured by enzyme-linked immunosorbent assay (ELISA) using capture and detection
antibodies against IL-6 (BD), IL-12p40 (BD) or TNFα (BioLegend).
8.2.9 ELISA (in vivo)
Whole blood was isolated via cardiac puncture, incubated at 4C for 3hrs and spun
at 15,000 g for 13 min at 4C. Serum was isolated and cytokines was measured by enzymelinked immunosorbent assay (ELISA) using capture and detection antibodies against IL12p40 (BD) or TNFα (BioLegend).
8.2.10 FasL stimulation of thymocytes and thymocyte characterization
1.5x105 thymocytes were plated in a 96-well flat bottom plate, and treated with
cycloheximide (25μg/mL) and anti-CD95 (Jo2, BD) at the indicated concentrations for
24hrs. Cells were treated with staurosporine (10μM) where indicated for 8hrs. Cells were
harvested and washed once in 4C sterile PBS. Cells were stained in Annexin V (Thermo
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Fisher) for 15 min, washed with Annexin binding buffer. Cells were stained with 7AAD
(Thermo Fisher), placed on ice and run immediately after staining.
Thymi were isolated from mice and processed into a single cell suspensions. 2x106
thymocytes were plated in 96-well U-bottom plates in sterile PBS and stained for viability
(Zombie Aqua, BioLegend) and then for CD4 (Bio Legend Clone-RM4-5), CD11b
(BioLegend Clone-M1/70), CD11c (BioLegend Clone-3.9), CD19 (BioLegend Clone1D3), CD49 (BioLegend Clone-9C10 (MFR4.B)), Gr-1 (BioLegend Clone-RB6-8C5),
CD25 (BioLegend Clone-PC61), TCRβ (BioLegend Clone-H57-597), CD8 (BioLegend
Clone-RPA-T8), CD44 (BioLegend Clone-BJ18), c-Kit (BioLegend Clone-2B8), CD5
(BioLegend Clone-53-7.3), and CD69 (BioLegend Clone-H1.2F3).

8.2.11 Flow cytometry (in vitro)
BMDMs were plated in 96 well-u-bottom plates and pre-treated with zVAD-fmk
(100 μM) for 1 hr prior to PAMP stimulation, where indicated. BFA and monensin were
added 1 hr later and samples were harvested for analysis 4–5 hrs later. Cells were washed
with PBS, stained for viability (Zombie Yellow, BioLegend), Il-12p40 (BD Clone-C15.6)
and pro-IL-1β(Thermo Fisher Clone NJTEN3). BMDMs were gated on live singlets. For
hc- experiments involving hc-Rel transfection, BMDMs were plated in 6-well suspension
dishes after electroporation. Electroporated BMDMs were stimulated with PAMPs 2 hrs
after electroporation, and brefeldin A/monensin (Sigma, BD) were added 1hr after PAMP
stimulation. Cells were harvested 3 hours later into PBS containing 2mM EDTA. Cells
were washed with PBS, stained for viability (Zombie Yellow, BioLegend), Il-12p40 (BD
Clone-C15.6), and pro-IL-1β(Thermo Fisher Clone NJTEN3).
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8.2.12 Flow cytometry (in vivo)
mLNs and PECs were isolated in 4C sterile PBS. RBCs were lysed in 1x ACK
buffer for 3min at room temperature. 1-2x106 PECs were plated in 96-well U-bottom T/C
treated plates in cDMEM with β-mercaptoethanol, Pen-Strep, and brefeldin A/monensin
(Sigma, BD) for 6hrs. 4-5x106 mLN cells were plated in 96-well U-bottom T/C treated
plates in cDMEM with β-mercaptoethanol, Pen-Strep, and brefeldin A/monensin (Sigma,
BD) for 6hrs. Cells were washed with PBS, stained for viability (Zombie Aqua or Zombie
Yellow, BioLegend) and stained for CD45.1 (BioLegend Clone-A20), CD45.2 (BioLegend
Clone-104), B220 (BioLegend Clone-RA3-6B2), CD3 (BioLegend Clone-17A2), CD19
(BioLegend Clone-1D3), NK1.1 (BioLegend Clone-PK136), MHCII (BioLegend CloneM5), Ly6G (BioLegend Clone-1A8), Ly6C (BioLegend Clone-HK1.4), CD11b
(BioLegend Clone-M1/70), CD11c (BioLegend Clone-3.9), CD64 (BioLegend Clone10.1), Il-12p40 (BD Clone-C15.6). Cells were gated on live singlets.

8.2.13 RNA-seq
1x106 BMDMs per well were plated in 6-well T/C-treated dishes and placed in a
5% CO2 37°C incubator for 16 hours. BMDMs were stimulated with LPS (100 ng/mL) or
CpG (1μM) for 0, 2, or 6 hrs. RNA was isolated using the RNeasy Mini Kit (Qiagen) and
processed per the manufacturer’s instructions. RNA-seq libraries were prepared using the
TruSeq Stranded Total RNA LT Kit with Ribo-Zero Gold, according to the manufacturer’s
instructions. Samples were run on Illumina NextSeq 500 to generate 75-base pair, single-
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end reads with a Q30 score of ~80%, resulting in 25–50 million fragments/sample.
Bioinformatic analyses were carried out as previously described[233]. Briefly, data
analyses were performed using the statistical computing environment R (v3.5.1), RStudio
(v1.1.456), and the Bioconductor suite of packages for R (http://www.bioconductor.org)
[234]. Fastq files were mapped to the mouse transcriptome (Ensembl, mouse cDNA
GRCh38) using Kallisto [235]. Reads were annotated with EnsemblDB [236] and
EnsDb.Mmusculus.v79 [237], and Tximport [238] was used to summarize transcripts to
genes. Data were log2 transformed and scaled using weighted trimmed mean of M-values
with (edgeR [239]). The prcomp function was used to perform principal component
analyses (PCA) on normalized data. Unsupervised hierarchical clustering and PCA plots
were visualized using ggplot2 [240]. For differential gene expression analysis, data were
filtered to remove unexpressed and lowly expressed (>1 count per million (cpm) across 2
or more samples. Differentially expressed genes (false discovery rate < 0.05 and absolute
log2 fold change >= 0.59), were identified using limma [241]. Heatmaps were created and
visualized using gplots [242]. Gene Ontology (GO) was performed using the Database for
Annotation, Visualization and Integration of Data (DAVID) [243]. HOMER transcription
factor motif analysis [61]was performed on a set of genes that were identified to be caspase8-dependent by the analysis described above. Raw data is available on the Gene Expression
Omnibus (GEO) (accession number pending).

8.2.14 RT-qPCR
1x106 BMDMs/well were plated in 6-well T/C-treated dishes 16 hrs before the
experiment. Cells were pre-treated with with IETD-fmk (500 μM) or zVAD-fmk (100 μM)
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prior to LPS (100 ng/mL) or CpG(1 μM) stimulation. Cells were harvested 2 hours post
stimulation and lysed in Trizol Reagent (Invitrogen/Thermo Fisher) and RNA was
extracted using the phenol/chloroform extraction method. RNA was resuspended in
RNAse-free water and cDNA synthesis was performed using High Capacity RNA to cDNA
kit (Thermo Fisher) as per the manufacturer’s instructions. qPCR was run using Power
Sybr Green Master Mix (Thermo Fisher) on a QuantStudio Flex6000 (Thermo Fisher).
Primer sequences used are listed in the Appendix.

8.2.15 Western Blots
BMDMs were seeded in TC-treated 48, 24 or 12 well plates. Where indicated
IETD-fmk (500 μM) or zVAD-fmk (100 μM) was used to inhibit caspase-8 activity for 1
hr before LPS (100ng/mL) or CpG(1 μM) stimulation. Cells were lysed at the indicated
times in lysis buffer (20 mM HEPES, 150 mM NaCl, 10% glycerol, 1% Triton X-100,
1mM EDTA, pH7.5) plus 1x complete protease inhibitor cocktail (Roche) and 1x sample
buffer (25 mM Tris, 2% SDS, 10% glycerol, 0.012% bromophenol blue, 0.2% βmercaptoethanol). Lysates were boiled at 110°C, spun at full speed for 5 minutes, run on
4-12% polyacrylamide gels (Invitrogen), and transferred to PVDF (Millipore). Membranes
were immunoblotted using the following primary antibodies: β-Actin (Sigma #A228,
1:5000), cRel (Santa Cruz sc-71X, 1:100), p65 (CST #8242 1:1000), IκBα (CST #9242,
1:1000), IκBε (Novus Biologics #AF4637, 1ug/mL) IκBβ (Novus Biologics #AF5225,
1ug/mL), pIKKα/β (CST #2697, 1:1000), IKKβ (CST #8943, 1:1000), p-p38 (CST
#9215,1:1000), p38 (CST #9212, 1:1000), GFP (Abcam ab6556, 1:1000), CYLD (Thermo
#43-700, 1:100), CNBP (Santa Cruz sc-515387, 1:100), HDAC1 (CST #34589S, 1:1000),
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Tubulin (Thermo #A11126, 1:5000), TAK1 (CST 1:1000), pTAK1 (Abcam pS439
1:1000), TBK1 (CST 1:000), pTBK1 (CST pS172 1:1000). Species specific HRPconjugated secondary antibodies were used for each antibody (1:5000). Membranes were
developed using Pierce ECL Plus and SuperSignal West Femto Maximum Sensitivity
Substrate (Fisher Scientific) according to the manufacturer’s instructions.
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8.3 Quantification and statistical analysis
Statistical significance for experiments with two groups was calculated using
Student’s two-tailed unpaired t-test. In the case of paired replicate experiments statistical
significance was calculated using Student’s two-tailed paired t-test. Adjusted p-values
were calculated using Prism 5.0 from GraphPad. n.s. denotes not significant; *, **, ***,
and **** illustrate p-values of 0.05, 0.01, 0.001, and 0.0001 respectively. Error bars
indicate ± SEM of at least three replicates. Investigators were not blinded to experimental
groups.
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8.4 Appendix
Table S1. Primer list for ChIP qPCR and cDNA amplification.
Gene
Target

Type

Forward

Reverse

Csf2

cDNA

GGCCTTGGAAGCATGTAGAGG

GAGAACTCGTTAGAGACGACTT

Gapdh

cDNA

CTCCCACTCTTCCACCTTCG

CCACCACCCTGTTGCTGTAG

Il12b

cDNA

TTGAAAGGCTGGGTATCGGT

GAATTTCTGTGTGGCACTGG

Il1b

cDNA

CCTCTGATGGGCAACCACTT

TTCATCCCCCACACGTTGAC

Il1a

cDNA

CGAAGACTACAGTTCTGCCATT GACGTTTCAGAGGTTCTCAGAG

Il4i1

cDNA

TCCAGCTTGAACCCTATTGAGA GTCCTGCATCACTGAGCATCT

Il6

cDNA

TCACTGGAGCCTCGAATGTC

GTGAGGAAGGCTGTGCATTG

Tnfsf9

cDNA

CGGCGCTCCTCAGAGATAC

ATCCCGAACATTAACCGCAGG

Gapdh

ChIP

GGTCCAAAGAGAGGGAGGAG

GCCCTGCTTATCCAGTCCTA

Hbb-bs

ChIP

GCATGGAAGACAGGACAATC

GTGGGAGGAGTGTACAAGGA

Il12b

ChIP

GGGGAGGGAGGAACTTCTTA

CTTTCTGATGGAAACCCAAAG

Il1b

ChIP

CCCACCCTTCAGTTTTGTTG

CTTGTTTTCCCTCCCTTGTTT

Il6

ChIP

AATGTGGGATTTTCCCATGA

GCTCCAGAGCAGAATGAGCTA

Tnf

ChIP

GATTCCTTGATGCCTGGGTGTC

GAGCTTCTGCTGGCTGGCTGT
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